<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Int J Microbiol</journal-id><journal-id journal-id-type="pmc-domain-id">985</journal-id><journal-id journal-id-type="pmc-domain">ijmb</journal-id><journal-id journal-id-type="publisher-id">IJMICRO</journal-id><journal-title-group><journal-title>International Journal of Microbiology</journal-title></journal-title-group><issn pub-type="ppub">1687-918X</issn><issn pub-type="epub">1687-9198</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12473729</article-id><article-id pub-id-type="pmcid-ver">PMC12473729.1</article-id><article-id pub-id-type="pmcaid">12473729</article-id><article-id pub-id-type="pmcaiid">12473729</article-id><article-id pub-id-type="doi">10.1155/ijm/8881117</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Virulence, Phylogenetic Grouping, and Antimicrobial Resistance Traits of Extraintestinal <italic toggle="yes">Escherichia coli</italic> in Clinical Isolates From Northwest Mexico</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6937-6853</contrib-id><name name-style="western"><surname>Casta&#241;eda-Mel&#233;ndrez</surname><given-names initials="AM">Ana Mar&#237;a</given-names></name><xref rid="I1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4662-3778</contrib-id><name name-style="western"><surname>Garc&#237;a-Cervantes</surname><given-names initials="PC">Patricia Catalina</given-names></name><xref rid="I1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1389-3568</contrib-id><name name-style="western"><surname>B&#225;ez-Flores</surname><given-names initials="ME">Mar&#237;a Elena</given-names></name><xref rid="I1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3416-8915</contrib-id><name name-style="western"><surname>Clemente-Soto</surname><given-names initials="AF">Aldo Francisco</given-names></name><xref rid="I1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7864-1292</contrib-id><name name-style="western"><surname>Barrios-Villa</surname><given-names initials="E">Edwin</given-names></name><xref rid="I2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9501-4514</contrib-id><name name-style="western"><surname>Bernal-Reynaga</surname><given-names initials="R">Rodolfo</given-names></name><email>rodolfobernal@uas.edu.mx</email><xref rid="I1" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Unit of Public Health Research &#8220;Dr. Kaethe Willms,&#8221; Doctorate in Biomedical Sciences, Faculty of Chemical-Biological Sciences, Autonomous University of Sinaloa, University City, Culiacan, Sinaloa, Mexico</aff><aff id="I2">
<sup>2</sup>Laboratory of Molecular Biology and Genomics, Department of Agricultural and Chemical-Biological Sciences, University of Sonora, Campus Caborca, Caborca, Sonora, Mexico</aff><author-notes><fn fn-type="other"><p>Academic Editor: Shibiao Wan</p></fn></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>19</day><month>9</month><year>2025</year></pub-date><volume>2025</volume><issue-id pub-id-type="pmc-issue-id">479293</issue-id><elocation-id>8881117</elocation-id><history><date date-type="received"><day>21</day><month>3</month><year>2025</year></date><date date-type="rev-recd"><day>26</day><month>6</month><year>2025</year></date><date date-type="accepted"><day>9</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>27</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 09:25:32.397"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 Ana Mar&#237;a Casta&#241;eda-Mel&#233;ndrez et al. International Journal of Microbiology published by John Wiley &amp; Sons Ltd.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="IJMICRO2025-8881117.pdf"/><abstract><p>
<italic toggle="yes">Escherichia coli</italic> is a highly diverse bacterial species that is canonically commensal; however, its genomic characteristics have enabled its evolution into pathogens capable of causing extraintestinal infections (ExPEC), which pose significant clinical challenges because of the variety of sites that can infect (mainly the urinary tract) and the multidrug resistance associated with these strains. The present study is aimed at characterizing ExPEC isolates recovered from the wards of a hospital in Sinaloa, Mexico, to establish their virulence and antimicrobial resistance profiles, as well as the phylogenetic group. Then, 200 <italic toggle="yes">Escherichia coli</italic> isolates and their antimicrobial susceptibility were confirmed by the VITEK-2 automated system. Virulence factor genes and phylogenetic grouping were performed through endpoint and multiplex PCRs. Then, 59% of the strains produced extended-spectrum <italic toggle="yes">&#946;</italic>-lactamases (ESBLs), and 71.5% were classified as multidrug resistant (MDR), exhibiting high resistance rates to antibiotics such as amoxicillin, ampicillin, ciprofloxacin, and various cephalosporins. In this sense, 68.5% and 33% of the isolates were positive for the <italic toggle="yes">blaCTX-M1-8</italic> and <italic toggle="yes">blaCTX-M9</italic> genes, respectively, both associated with resistance to cefotaxime. Furthermore, 37% of the isolates harbored the <italic toggle="yes">blaOXA48</italic> gene, which is linked to resistance to oxacillin-type <italic toggle="yes">&#946;</italic>-lactams. Moreover, 143 (71.5%) of them were classified as MDR. Regarding virulence, the distribution of toxin genes such as <italic toggle="yes">hlyA</italic> and <italic toggle="yes">vat</italic> was 16.5% and 24.5%, respectively. Adhesins <italic toggle="yes">papC</italic> and <italic toggle="yes">fimA</italic> were found in 62% and 34%, respectively. Additionally, the iron acquisition systems and outer membrane proteins such as <italic toggle="yes">iutA</italic> (74%), <italic toggle="yes">fyuA</italic> (63%), <italic toggle="yes">iroN</italic> (10%), <italic toggle="yes">agn43</italic> (82%), and <italic toggle="yes">kpsmTII</italic> (34.5%) were present in the isolates. Phylogenetic analysis showed a predominance of group B2 (46%), followed by groups A (13.5%) and E (10.5%). These findings highlight the complexity and challenges posed by ExPEC strains in terms of antimicrobial resistance and virulence relevant to public health in hospital settings.</p></abstract><kwd-group kwd-group-type="Inspec"><title>Keywords</title><kwd>antimicrobial resistance</kwd><kwd>extraintestinal pathogenic <italic toggle="yes">Escherichia coli</italic></kwd><kwd>multidrug-resistant strains</kwd><kwd>phylogeny</kwd><kwd>virulence factors</kwd></kwd-group><funding-group><award-group><funding-source>Secretariat of Science, Humanities, Technology, and Innovation</funding-source><award-id>1007906</award-id></award-group><award-group><funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://dx.doi.org/10.13039/501100016234">Universidad Aut&#243;noma de Sinaloa</funding-source><award-id>PRO_A2_006</award-id></award-group><funding-statement>The study was supported by the &#8216;Programa de Fomento y Apoyo a Proyectos de Investigaci&#243;n' (PROFAPI 2022) of the Universidad Autonoma de Sinaloa, PRO_A2_006. We acknowledge the Secretariat of Science, Humanities, Technology, and Innovation (SECIHTI) for the Doctoral Scholarship (No. 1007906) awarded to Ana Mar&#237;a Casta&#241;eda-Mel&#233;ndrez.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>
<italic toggle="yes">Escherichia coli</italic> inhabits the human intestine and plays a crucial role in the digestion and balance of the intestinal microbiota. However, a few strains of <italic toggle="yes">E. coli</italic> have evolved into potential pathogens that can cause various diseases in humans. These pathogenic strains pose a constant challenge to public health worldwide, as they can lead to diseases ranging from mild gastroenteritis to severe infections, such as sepsis and hemolytic uremic syndrome [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. Pathogenic <italic toggle="yes">E. coli</italic> strains are divided into two main groups: diarrheagenic <italic toggle="yes">Escherichia</italic> coli (DEC) and extraintestinal pathogenic <italic toggle="yes">Escherichia coli</italic> (ExPEC); these latter strains are specialized subsets of <italic toggle="yes">E. coli</italic> distinguished by their ability to cause infections in various parts of the body, outside of the gastrointestinal tract [<xref rid="B3" ref-type="bibr">3</xref>].</p><p>Among the most prevalent infections attributed to ExPEC are urinary tract infections (UTIs), associated with strains of uropathogenic <italic toggle="yes">Escherichia coli</italic> (UPEC). These pathogenic strains can ascend from the urethra to the bladder (where they cause cystitis) and the kidneys (pyelonephritis), resulting in distressing symptoms and potentially severe conditions [<xref rid="B4" ref-type="bibr">4</xref>]. Furthermore, ExPEC strains can potentially induce sepsis, a systemic inflammatory response to infection that poses a life-threatening risk. Sepsis generally originates from an infection source elsewhere in the body, such as the urinary tract or soft tissue, predominantly instigated by sepsis-associated <italic toggle="yes">Escherichia coli</italic> (SEPEC). Additionally, under certain circumstances, ExPEC can trigger infections in wounds, abscesses, or soft tissues, resulting in localized inflammation and infection. In some cases, particularly in neonates, ExPEC can be accountable for severe infections like sepsis and meningitis, which can have devastating consequences, primarily attributed to neonatal <italic toggle="yes">Escherichia coli</italic> meningitis (NEMEC) [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>].</p><p>The pathogenicity of these strains is intrinsically associated with a repertoire of virulence factors that facilitate their adherence to host cells, colonization of human tissues, evasion of the immune system, infliction of damage, and acquisition of essential nutrients required for growth and survival [<xref rid="B7" ref-type="bibr">7</xref>&#8211;<xref rid="B9" ref-type="bibr">9</xref>].</p><p>These <italic toggle="yes">E. coli</italic> strains can be classified into eight phylogroups, seven belonging to <italic toggle="yes">E. coli sensu stricto</italic> (A, B1, B2, C, D, E, F, and G) and one belonging to the <italic toggle="yes">Escherichia</italic> cryptic clades I&#8211;V [<xref rid="B10" ref-type="bibr">10</xref>&#8211;<xref rid="B12" ref-type="bibr">12</xref>]. Most strains responsible for extraintestinal infections belong to group B2, with some in group D, whereas commensal strains belong to groups A, B1, and C [<xref rid="B13" ref-type="bibr">13</xref>&#8211;<xref rid="B15" ref-type="bibr">15</xref>]. On the other hand, antibiotic resistance poses a mounting concern in the treatment of infections caused by pathogenic <italic toggle="yes">E. coli</italic> strains. The ability of these bacteria to acquire and disseminate antibiotic-resistant genes represents a substantial challenge in clinical therapy. The emergence of multidrug-resistant (MDR) ExPEC strains further complicates the management of these infections, rendering the selection of effective therapies a complicated task [<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>].</p><p>In Mexico and particularly in Sinaloa, studies on ExPEC are scarce. One study reported the presence of MDR UPEC strains isolated from UTIs in pregnant women. The isolates had virulence factors, such as membrane-associated (<italic toggle="yes">agn43</italic>) and adhesins (<italic toggle="yes">fimH</italic> and <italic toggle="yes">papC</italic>), and resistance to multiple antibiotics was observed [<xref rid="B18" ref-type="bibr">18</xref>]. Other studies have identified strains belonging to the B2 phylogenetic group in clinical <italic toggle="yes">E. coli</italic> isolates from children with diarrhea and associated these characteristics with their antimicrobial resistance [<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>].</p><p>Given the limited information available on ExPEC strains in northwestern Mexico and their potential clinical impact, this study is aimed at characterizing their antimicrobial resistance profiles, assessing the presence and distribution of key virulence factor genes, and determining their phylogenetic classification. We hypothesized that these clinical isolates would exhibit high levels of multidrug resistance and harbor a diverse repertoire of virulence genes, reflecting their adaptation to extraintestinal pathogenicity and their potential threat to public health in hospital settings.</p><p>In this sense, the present study is aimed at molecularly characterizing extraintestinal <italic toggle="yes">E. coli</italic> strains derived from diverse clinical isolates and establishing their virulence and antimicrobial resistance profile and phylogenetic group.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Clinical Isolates</title><p>Clinical isolates were obtained from inpatients and outpatients at the General Hospital of Culiacan in the period from July 2022 to March 2023; samples were obtained from different anatomical sites. Isolates identified as <italic toggle="yes">E. coli</italic> through Vitek 2 (BioM&#233;rieux, France) were transported to the Public Health Research Unit &#8220;Dr. Kaethe Willms&#8221; of the Faculty of Chemical and Biological Sciences at the Autonomous University of Sinaloa for subculturing on MacConkey agar plates from 18 to 24&#8201;h at 37&#176;C.</p></sec><sec id="sec2.2"><title>2.2. Antimicrobial Susceptibility Profile of the Isolates</title><p>Antibiotic susceptibility testing was performed using AST-N402 cards in the Vitek 2 automated system (BioM&#233;rieux, France) according to CLSI 2024 specifications [<xref rid="B21" ref-type="bibr">21</xref>]. VITEK 2 automatically categorizes isolates as susceptible, intermediate, or resistant based on CLSI-defined minimum inhibitory concentration (MIC) breakpoints for the tested antibiotics in the automated antimicrobial susceptibility test (Table <xref rid="supplementary-material-1" ref-type="sec">S1</xref>). The antibiotics considered included aminopenicillins (ampicillin), <italic toggle="yes">&#946;</italic>-lactam combination agents (ampicillin&#8211;sulbactam and piperacillin&#8211;tazobactam), first-generation cephalosporins (cephalothin), second-generation cephalosporins (cefuroxime), third-generation cephalosporins (cefotaxime, ceftazidime, and ceftriaxone), fourth-generation cephalosporins (cefepime), penicillins (piperacillin), cephems (cefepime and ceftriaxone), aminoglycosides (gentamicin and amikacin), fluoroquinolones (ciprofloxacin), nitrofurans (nitrofurantoin), carbapenems (meropenem and ertapenem), and folate-pathway antagonists (trimethoprim&#8211;sulfamethoxazole).</p></sec><sec id="sec2.3"><title>2.3. Genomic DNA Extraction</title><p>DNA was extracted using the heat-shock method. Briefly, five bacterial colonies were resuspended in 1-mL nuclease-free water. The suspension was homogenized with a vortex and immersed in water at 100&#176;C for 1&#8201;min. The bacterial lysate was transferred to ice for 20&#8201;min and stored at &#8722;20&#176;C until use.</p></sec><sec id="sec2.4"><title>2.4. Identification of Virulence Factor Genes</title><p>The <italic toggle="yes">hlyA</italic> gene (1177&#8201;bp) (<xref rid="tab1" ref-type="table">Table 1</xref>) was identified using conventional endpoint PCR. The reaction mixture included 2X Green GoTaq Flexi Buffer (Promega), 2.5&#8201;U of GoTaq Flexi DNA Polymerase (Promega), 2&#8201;mM MgCl<sub>2</sub> (Promega), 250&#8201;<italic toggle="yes">&#956;</italic>M of the dNTP mix (Promega), 0.6&#8201;<italic toggle="yes">&#956;</italic>M of each oligonucleotide, and 50&#8201;ng of DNA for a final volume of 25&#8201;<italic toggle="yes">&#956;</italic>L. The amplification protocol consisted of an initial denaturation cycle at 95&#176;C for 5&#8201;min, followed by 35 cycles of 94&#176;C for 30&#8201;s, 66&#176;C for 40&#8201;s, and 68&#176;C for 1&#8201;min, and a final extension cycle at 72&#176;C for 10&#8201;min. The strain O30U was used as the positive control [<xref rid="B29" ref-type="bibr">29</xref>].</p><p>The <italic toggle="yes">vat</italic>, <italic toggle="yes">papC</italic>, <italic toggle="yes">fimA</italic>, and <italic toggle="yes">fyuA</italic> genes were amplified by multiplex PCR, referred to as ExPEC. The reaction mixture included 2X Green GoTaq Flexi Buffer (Promega), 1.5&#8201;U of GoTaq Flexi DNA Polymerase (Promega), 1.6&#8201;mM MgCl<sub>2</sub> (Promega), 100&#8201;<italic toggle="yes">&#956;</italic>M dNTPs (Promega), the mixture of the four pairs of oligonucleotides (<xref rid="tab1" ref-type="table">Table 1</xref>), and 50&#8201;ng of DNA, for a final volume of 25&#8201;<italic toggle="yes">&#956;</italic>L. The amplification protocol involved an initial denaturation cycle at 95&#176;C for 5&#8201;min, followed by 35 cycles of 95&#176;C for 5&#8201;min, 94&#176;C for 30&#8201;s, 61&#176;C for 1&#8201;min, and a final extension cycle at 72&#176;C for 10&#8201;min. Clinical isolates 2H25B, V27, and O30U were used as positive controls [<xref rid="B28" ref-type="bibr">28</xref>].</p><p>Additionally, <italic toggle="yes">iutA</italic>, <italic toggle="yes">agn43</italic>, <italic toggle="yes">kpsmTII</italic>, and <italic toggle="yes">iroN</italic> were identified by multiplex PCR referred to as UPEC. The reaction mixture consisted of 1X Green GoTaq Flexi Buffer (Promega), 0.5&#8201;U of GoTaq Flexi DNA Polymerase (Promega), 1.8&#8201;mM of MgCl<sub>2</sub> (Promega), 62&#8201;<italic toggle="yes">&#956;</italic>M of the dNTP mix (Promega), the mix containing the four pairs of oligonucleotides, and 50&#8201;ng of DNA, for a final volume of 25&#8201;<italic toggle="yes">&#956;</italic>L. The amplification protocol included an initial denaturation step at 95&#176;C for 5&#8201;min, followed by 35 cycles of denaturation at 94&#176;C for 30&#8201;s, annealing at 63&#176;C for 30&#8201;s, extension at 68&#176;C for 1&#8201;min, and a final extension step at 72&#176;C for 10&#8201;min, using the V27 strain as a positive control.</p></sec><sec id="sec2.5"><title>2.5. Determination of Phylogenetic Group</title><p>All isolates were subject to phylogenetic analysis according to Clermont et al. [<xref rid="B11" ref-type="bibr">11</xref>] and classified as belonging to one of the eight phylogenetic groups (A, B1, B2, C, D, E, and F). The reaction mixture for this protocol included 1X Green GoTaq Flexi Buffer (Promega), 1.5&#8201;U of GoTaq Flexi DNA Polymerase (Promega), 1.6&#8201;mM MgCl<sub>2</sub> (Promega), 100&#8201;<italic toggle="yes">&#956;</italic>M dNTPs (Promega), the mixture of the oligonucleotides (<xref rid="tab2" ref-type="table">Table 2</xref>), and 50&#8201;ng of DNA, for a final volume of 10&#8201;<italic toggle="yes">&#956;</italic>L.</p><p>PCR reactions were performed under the following conditions: denaturation for 4&#8201;min at 94&#176;C, 30 cycles of 5&#8201;s at 94&#176;C and 20&#8201;s at 57&#176;C (group E) or 59&#176;C (quadruplex and group C), and a final extension step of 5&#8201;min at 72&#176;C. The primers used for the allele-specific phylo-groups E and C PCRs were ArpAgpE.f and ArpAgpE.r and trpAgpC.f and trpAgpC.r, respectively, using the strains CFT073 and ATCC 25922 as positive controls [<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B31" ref-type="bibr">31</xref>].</p></sec><sec id="sec2.6"><title>2.6. Identification of <italic toggle="yes">&#946;</italic>-Lactamase Genes</title><p>All isolates were subjected to the detection of genes associated with <italic toggle="yes">&#946;</italic>-lactamase production by endpoint PCR. Each reaction contained 0.4&#8201;<italic toggle="yes">&#956;</italic>M of each primer, GoTaq MasterMix (Promega Corporation, Madison WI, United States) (including reaction buffer, 400&#8201;<italic toggle="yes">&#956;</italic>M of each dNTP, 3&#8201;mM MgCl<sub>2</sub>, and 1&#215; Taq DNA polymerase) to a final volume of 10&#8201;<italic toggle="yes">&#956;</italic>L. PCR reactions were performed under the following conditions: denaturation for 1&#8201;min at 94&#176;C, 35 cycles of 1&#8201;min at 94&#176;C, 40&#8201;s at 55&#176;C, 1&#8201;min at 72&#176;C, and a final extension step of 10&#8201;min at 72&#176;C. The primers used are in <xref rid="tab3" ref-type="table">Table 3</xref>, using the strain AL74 as the positive control.</p><p>All PCR products were obtained using a MiniAmp Plus thermal cycler (Applied BioSystems, United States). The amplicons were resolved on a 1.5% agarose gel electrophoresis and stained with Ultra GelRed (10,000&#215;) (Bio-Sigma) and visualized using a UVP Transilluminator (AnalytikJena, United States).</p><p>Quality control was ensured by including positive control strains for each PCR assay. Clinical isolates previously characterized and confirmed to carry the relevant virulence genes such as O30U, V27, and 2H25B were used as positive controls in the amplification of specific virulence factors. For phylogenetic group assignment, the reference strains <italic toggle="yes">E. coli</italic> CFT073 and ATCC 25922 were included as controls for specific allele amplification, following standard procedures. For the identification of genes associated with <italic toggle="yes">&#946;</italic>-lactamase production, the control strain AL74 of <italic toggle="yes">Leclercia adecarboxylata</italic>, previously isolated from raw vegetables, was employed as a positive control. These controls allowed verification of PCR reagent performance, primer specificity, and amplification conditions throughout the study.</p></sec><sec id="sec2.7"><title>2.7. Visualization of Resistance Relationships</title><p>Resistance relationships were depicted using the online Circos Plot tool 23. The visualization was created based on binary data indicating whether each isolate was resistant or not to the antibiotics tested. Connections between antibiotics were determined by visually identifying shared resistance patterns among isolates, without performing any formal statistical analysis to measure the strength or significance of these links. Thus, the Circos plot serves as an exploratory visualization to suggest possible patterns of cross-resistance.</p></sec><sec id="sec2.8"><title>2.8. Statistical Analysis</title><p>The data were analyzed using GraphPad Prism Version 9 software. The association between phylogenetic groups and the presence of virulence genes was assessed using the Chi-square test and Fisher's test, as applicable. The level of significance was set at <italic toggle="yes">p</italic> &lt; 0.05.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Patients and Isolate Origin</title><p>A total of 200 <italic toggle="yes">E. coli</italic> isolates were collected at the General Hospital of Culiacan from July 2022 to March 2023. During this period, female patients (105 samples, 52.5%) were more affected by these infections than male patients (95 samples, 47.5%), with ages ranging from 9 to 93 years old. The isolates were obtained from different anatomical sites of the patients in the different hospital wards, including urine cultures (163), wounds (18), sputum (6), blood cultures (4), catheter tips (3), peritoneal fluid (2), hemodialysis (1), bronchial aspirates (1), otic (1), and ascitic fluid (1) (<xref rid="tab4" ref-type="table">Table 4</xref>).</p></sec><sec id="sec3.2"><title>3.2. Antimicrobial Resistance of Isolates</title><p>The antimicrobial resistance and the number of isolates assessed for each antibiotic are shown in <xref rid="fig1" ref-type="fig">Figure 1</xref>. High frequencies of resistance were observed against amoxicillin (87.5%), ampicillin (82.6%), ciprofloxacin (75.3%), cephalotin (69.2%), norfloxacin (68.6%), cefotaxime (67.3%), and cefuroxime&#8211;axetil (66.7%). Additionally, 59% of the isolates tested positive for extended-spectrum <italic toggle="yes">&#946;</italic>-lactamases (ESBLs), as determined using AST-N402 cards in the Vitek 2 automated system (BioM&#233;rieux, France) according to CLSI 2024 specifications [<xref rid="B21" ref-type="bibr">21</xref>].</p><p>Additionally, 68.5% and 33% of the isolates tested positive for the <italic toggle="yes">blaCTX-M1-8</italic> and <italic toggle="yes">blaCTX-M9</italic> genes, respectively, both associated with resistance to cefotaxime. Furthermore, 37% of the isolates harbored the <italic toggle="yes">blaOXA48</italic> gene, which is linked to resistance to oxacillin-type <italic toggle="yes">&#946;</italic>-lactams. Moreover, 143 (71.5%) of them were classified as MDR. The Circos plot (<xref rid="fig1" ref-type="fig">Figure 1</xref>) visually revealed several notable cross-resistance patterns. The most prominent associations involved resistance overlaps between ampicillin and amoxicillin, ciprofloxacin and norfloxacin, and among third- and fourth-generation cephalosporins such as cefotaxime, ceftriaxone, and cefepime. These findings suggest the presence of MDR phenotypes encompassing <italic toggle="yes">&#946;</italic>-lactams and fluoroquinolones, which are commonly utilized in clinical practice.</p></sec><sec id="sec3.3"><title>3.3. Virulence Factor Genes and Phylogenetic Grouping of the Isolates</title><p>Regarding virulence genes in the isolates, the most prevalent gene found in the isolates was the one coding for <italic toggle="yes">fimH</italic> (95.5%), followed by <italic toggle="yes">agn43</italic> (82%), <italic toggle="yes">fyuA</italic> (63%), and <italic toggle="yes">papC</italic> (62%). Phylogenetic grouping showed that phylogroup B2 (46%) was the most prevalent among the isolates, then the phylogroups A (13.5%) and E (10.5%) (<xref rid="tab5" ref-type="table">Table 5</xref>).</p></sec><sec id="sec3.4"><title>3.4. Most Represented Profiles of the Isolates With Multiple Virulence Genes</title><p>Based on genotyping, representative virulence profiles were identified, showing the combination of genes present in our isolates (<xref rid="tab6" ref-type="table">Table 6</xref>). Interestingly, all isolates showed at least one of the virulence genes analyzed, and the combination of six genes (<italic toggle="yes">papC&#8201;+&#8201;fyuA&#8201;+&#8201;kpsmTII&#8201;+&#8201;agn43&#8201;+&#8201;iutA&#8201;+&#8201;fimH</italic>) was the most prevalent in the isolates (17), and only two strains presented all the genes.</p><p>Contingency tables were constructed to assess the possible association between phylogenetic groups and the presence of virulence genes in the strains; however, no significant associations were observed, considering <italic toggle="yes">p</italic>&#8201;values &#8804; 0.05 as statistically significant.</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>Pathogenic strains of <italic toggle="yes">E. coli</italic>, particularly ExPEC, are significant contributors to various infections and represent an ongoing public health concern [<xref rid="B2" ref-type="bibr">2</xref>]. The distribution of the isolates among patients, clinical characteristics, and hospital services provides valuable insight into the epidemiology of infections caused by these microorganisms.</p><p>In the present study, 200 ExPEC were evaluated to determine their antimicrobial resistance profile, identify virulence genes, and assign phylogenetic groups using PCR. The results highlight the diverse nature of infections in a hospital setting. Most isolates were associated with UTIs, reflecting the prevalence of this type of infection in the current clinical context. This finding is consistent with recent literature indicating that <italic toggle="yes">E. coli</italic> is the most common pathogen associated with UTIs, accounting for approximately 80%&#8211;90% of cases in both inpatient and outpatient settings [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>]. Sex distribution showed an equitable representation in most categories, with a slight female predominance in the urine culture group. This observation can be attributed to the anatomical differences in women. Additionally, the ability of <italic toggle="yes">E. coli</italic> to colonize various anatomical sites is influenced by genomic plasticity and remodeling, which involves the acquisition or loss of genetic material. This process leads to the development of resistance or virulence factors. The severity of ExPEC infections can vary, influenced by specific virulence factors, host susceptibility, and immune response [<xref rid="B35" ref-type="bibr">35</xref>&#8211;<xref rid="B38" ref-type="bibr">38</xref>].</p><p>We observed a prevalence of MDR and ESBL production in 71.5% and 59% of isolates, respectively. This finding aligns with studies identifying the misuse of antibiotics as a critical factor in the development of resistant strains. Additionally, high resistance rates to common antibiotics amoxicillin (87.5%), ampicillin (82.6%), ciprofloxacin (75.3%), cephalotin (69.2%), norfloxacin (68.6%), cefotaxime (67.3%), and cefuroxime&#8211;axetil (66.7%) demonstrate the increasing resistance of <italic toggle="yes">E. coli</italic> to these drug classes.</p><p>The high resistance rates observed in our isolates, particularly to aminopenicillins, fluoroquinolones, and cephalosporins, can be understood within the broader context of antimicrobial use in Mexico. Studies have reported widespread empirical use of <italic toggle="yes">&#946;</italic>-lactams and fluoroquinolones in both community and hospital settings, often without culture-based guidance, contributing to selective pressure and the emergence of MDR strains [<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B35" ref-type="bibr">35</xref>]. Although national treatment guidelines (e.g., NOM-045-SSA2-2005 for UTIs) provide recommendations, adherence can vary across institutions. In addition, over-the-counter antibiotic access has historically contributed to misuse, although recent regulatory efforts have sought to reduce this practice.</p><p>At the molecular level, resistance in <italic toggle="yes">E. coli</italic> is commonly mediated by the production of ESBLs, particularly enzymes encoded by <italic toggle="yes">blaCTX-M</italic>, <italic toggle="yes">blaTEM</italic>, and <italic toggle="yes">blaSHV</italic>. In our study, 68.5% and 33% of the isolates tested positive for the <italic toggle="yes">blaCTX-M1-8</italic> and <italic toggle="yes">blaCTX-M9</italic> genes, respectively, both associated with resistance to cefotaxime. Furthermore, 37% of the isolates harbored the <italic toggle="yes">blaOXA48</italic> gene, which is linked to resistance to oxacillin-type <italic toggle="yes">&#946;</italic>-lactams. These findings are consistent with recent global studies that report widespread dissemination of <italic toggle="yes">blaCTX-M</italic> variants, particularly <italic toggle="yes">CTX-M-15</italic>, in clinical settings. For example, a 2023 meta-analysis estimated a pooled prevalence of 37.55% for <italic toggle="yes">blaCTX-M</italic> among human <italic toggle="yes">E. coli</italic> isolates, while <italic toggle="yes">blaOXA</italic> was present in 16% of cases [<xref rid="B39" ref-type="bibr">39</xref>]. In a 2024 study from Tunisia, 92% of ESBL-producing <italic toggle="yes">E. coli</italic> carried <italic toggle="yes">blaCTX-M</italic> [<xref rid="B40" ref-type="bibr">40</xref>]. Notably, colocalization of <italic toggle="yes">blaCTX-M</italic> and <italic toggle="yes">blaOXA-1</italic> on IncI2-type plasmids has also been reported in China, suggesting a growing trend of mobile genetic elements facilitating the spread of multidrug resistance [<xref rid="B41" ref-type="bibr">41</xref>].</p><p>Several authors have reported that some strains may exhibit cross-resistance, defined as resistance to multiple distinct antimicrobial agents conferred by a single molecular mechanism [<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B42" ref-type="bibr">42</xref>]. This trait may be present in our strains, as the Circos plot analysis suggests that strains developing resistance to one antibiotic often exhibit resistance to others within the same or different classes.</p><p>ExPEC strains harbored key virulence factors associated with pathogenicity. Among adhesins, <italic toggle="yes">fimA</italic>, <italic toggle="yes">papC</italic>, and <italic toggle="yes">fimH</italic> were prevalent in 34%, 62%, and 95.5% of isolates, respectively. These genes are essential for colonization and adhesion to host tissues, facilitating the development of persistent infections [<xref rid="B43" ref-type="bibr">43</xref>]. A study conducted in Mexico by Ballesteros-Monrreal et al. [<xref rid="B26" ref-type="bibr">26</xref>] evaluated 95 isolates from urinary tract infections and reported that <italic toggle="yes">fimH</italic> was the most prevalent virulence factor (100%), which aligns with the findings of this study (95.5%). The widespread presence of this adhesin, with reported prevalence ranging from 86% to 100% among clinically isolated UPEC strains, underscores its crucial role in the pathogenesis of urinary tract infections. Accordingly, <italic toggle="yes">fimH</italic> is widely recognized as a key molecular marker of virulence in UPEC, as documented by several authors worldwide [<xref rid="B44" ref-type="bibr">44</xref>&#8211;<xref rid="B47" ref-type="bibr">47</xref>].</p><p>Additionally, the prevalence of iron acquisition systems such as <italic toggle="yes">iutA</italic>, <italic toggle="yes">fyuA</italic>, and <italic toggle="yes">iroN</italic> (74%, 63%, and 10%, respectively) underscores the importance of efficient iron uptake for ExPEC survival and proliferation within the host [<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B47" ref-type="bibr">47</xref>]. Regarding toxins, the genes <italic toggle="yes">vat</italic> (24.5%) and <italic toggle="yes">hlyA</italic> (16.5%) were identified. These virulence factors are thought to contribute to tissue damage and the severity of infections [<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>].</p><p>Collectively, virulence factors contribute to ExPEC's ability to adhere to host cells, evade the immune system, and establish persistent infections. In this study, we identified multiple gene combinations, with the most prevalent profile&#8212;detected in 17 isolates being&#8212;<italic toggle="yes">papC&#8201;+&#8201;fyuA&#8201;+&#8201;kpsmTII&#8201;+&#8201;agn43&#8201;+&#8201;iutA&#8201;+&#8201;fimH</italic>. This profile comprises three of the four virulence factors investigated, which are associated with adhesin production, membrane stability, and nutrient acquisition. Additionally, two isolates were found to harbor all the virulence factors analyzed in this study. This finding is particularly relevant, as the combination of genes from various functional groups supports previous discussions by several authors regarding the potential relationship between the number of virulence genes in ExPEC strains and their high pathogenicity, as well as their capacity to cause infections in various human anatomical sites [<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>].</p><p>Another noteworthy finding is the identification of various hemolysis patterns among <italic toggle="yes">hlyA</italic>-positive isolates. Hemolysis is a complex phenomenon influenced by multiple factors, including the type and quantity of hemolysin produced, as well as the specific host environment [<xref rid="B7" ref-type="bibr">7</xref>]. Alpha hemolysis, observed in one-fourth of <italic toggle="yes">hlyA</italic>-positive isolates (data not shown), suggests diversity in the hemolytic activity of ExPEC strains.</p><p>The recent study by Praetorius in 2021 [<xref rid="B50" ref-type="bibr">50</xref>] expands the understanding of the cellular mechanisms affected by HlyA, demonstrating that this toxin not only causes physical damage through pore formation but also activates intracellular signaling pathways linked to inflammatory responses and programed cell death. These complex interactions enable ExPEC strains to persist within the host and exacerbate the severity of infections. Further research on factors affecting hemolysis patterns, such as variations in hemolysin expression or the presence of other regulatory elements, could provide valuable insights into the pathogenicity of these strains.</p><p>ExPEC isolates were assigned to eight major phylogenetic groups (A, B1, B2, C, D, E, F, and G). The predominant group was B2 (46%), followed by A (13.5%), E (10.5%), B1 (8%), D (8.5%), unknown (5%), F (4.5%), C (4%), and G (0%). This distribution slightly differs from the findings of Ballesteros-Monrreal et al. [<xref rid="B14" ref-type="bibr">14</xref>], who reported that ExPEC strains predominantly belong to phylogenetic groups B2 and D. These groups possess a higher number of virulence determinants compared to commensal strains, which belong to phylogenetic groups A and B1. Some reports suggest that UPEC can be distributed across all phylogenetic groups, with the migration of fecal strains to the urinary tract [<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B51" ref-type="bibr">51</xref>].</p><p>A study conducted in Mexico by Bravata-Alc&#225;ntara et al. [<xref rid="B15" ref-type="bibr">15</xref>] revealed that, of 107 isolates evaluated, most ExPEC isolates associated with extraintestinal infections belonged to phylogenetic group B2 (42.5%), followed by group A (27.1%), D (24.29%), and B1 (6.54%). The high prevalence of nonpathogenic strains from phylogenetic group A in this study may also be attributed to the migration of these intestinal strains to the urinary tract, where they serve as reservoirs of virulence factor genes and may become virulent through adaptations to pathogenic environments. Moreover, it is unclear whether <italic toggle="yes">E. coli</italic> strains should be classified as commensal or pathogenic based solely on the sample source or phylogenetic group, as phylogenetic group A can cause extraintestinal infections in immunocompromised individuals [<xref rid="B51" ref-type="bibr">51</xref>].</p><p>The predominance of phylogenetic group B2 (46%) in our isolates aligns with previous studies that describe this group as the most common among ExPEC strains worldwide. Group B2 is known to harbor a higher number of virulence-associated genes, including adhesins, iron acquisition systems, and toxins, which contribute to its enhanced pathogenic potential and adaptability in extraintestinal sites [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B48" ref-type="bibr">48</xref>]. This group's genetic background may facilitate colonization, immune evasion, and persistence in clinical settings, particularly in urinary tract infections and sepsis.</p><p>Interestingly, a notable proportion of isolates belonged to phylogenetic group A (13.5%), which is generally associated with commensal <italic toggle="yes">E. coli.</italic> However, recent studies suggest that group A strains can acquire virulence and resistance determinants through horizontal gene transfer and may act as opportunistic pathogens, especially in immunocompromised hosts or under hospital selective pressures [<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B51" ref-type="bibr">51</xref>]. The elevated presence of group A strains in this study may reflect such adaptive processes, highlighting the fluid boundaries between commensalism and pathogenicity within the <italic toggle="yes">E. coli</italic> species complex.</p><p>Understanding the molecular and phenotypic characteristics of ExPEC strains is essential for designing effective control and treatment strategies. The prevalence of antimicrobial resistance emphasizes the importance of prudent antibiotic use and the development of alternative therapeutic approaches. Moreover, identifying specific virulence factors and hemolysis patterns can aid in risk assessment and the prediction of clinical outcomes of ExPEC infections.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>This investigation underscores the clinical and epidemiological significance of ExPEC strains in northwest Mexico (Sinaloa). Overall, the diversity in patient attributes, services, and sources of isolates highlights the versatility of <italic toggle="yes">E. coli</italic> in causing infections across different anatomical sites and patient populations. The data presented here contribute to a comprehensive understanding of the clinical and epidemiological aspects of ExPEC infections in the studied hospital setting. Further investigations could explore associations between specific patient characteristics and the severity or outcomes of ExPEC infections.</p><sec id="sec5.1"><title>5.1. Limitations and Future Directions</title><p>This study has certain limitations that should be acknowledged. First, the lack of whole-genome sequencing (WGS) and multilocus sequence typing (MLST) restricted our ability to explore the clonal structure and potential transmission routes of the ExPEC isolates in depth. Although incorporating these techniques was beyond the scope of the present study, we recognize that their absence limits the genomic resolution of our findings. Despite this, we believe that epidemiological surveillance of potential pathogenic strains should be conducted using the available tools.</p></sec></sec></body><back><ack><title>Acknowledgments</title><p>We acknowledge the Secretariat of Science, Humanities, Technology, and Innovation (SECIHTI) for the Doctoral Scholarship (No. 1007906) awarded to Ana Mar&#237;a Casta&#241;eda-Mel&#233;ndrez. We also thank Microbiologist Jos&#233; Trinidad Rodr&#237;guez Atondo from the General Hospital of Culiac&#225;n for providing the bacterial isolates, as well as Dr. Mar&#237;a Teresa Estrada Garc&#237;a and Dr. Catalina L&#243;pez Saucedo for providing the clinical isolates used as positive controls in our study.</p></ack><sec sec-type="data-availability"><title>Data Availability Statement</title><p>The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.</p></sec><sec sec-type="ethics-statement"><title>Ethics Statement</title><p>This study was approved by the Bioethics Committee of the General Hospital of Culiac&#225;n &#8220;Dr. Bernardo J. Gast&#233;lum&#8221; with COFEPRIS registration number 17 CI 25 006 089 and file number 001280.</p></sec><sec><title>Disclosure</title><p>The funding institution has no role in the design of the project, work execution, analysis, interpretation of the data, and manuscript writing or submission. All authors read, reviewed, and approved the final version of the manuscript.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec><title>Author Contributions</title><p>R.B.-R., P.C.G.-C., A.F.C.-S., E.B.-V., and M.E.B.-F. conceived and designed the study. A.M.C.-M., P.C.G.-C., and R.B.-R. performed the experiments and analyzed the data. R.B.-R., A.M.C.-M., and E.B.-V. wrote the paper.</p></sec><sec sec-type="supplementary-material" id="supplementary-material-1"><title>Supporting Information</title><supplementary-material id="supp-1" position="float" content-type="local-data" orientation="portrait"><label>Supporting Information</label><caption><p>Additional supporting information can be found online in the Supporting Information section. Table S1: Minimum inhibitory concentration (MIC) breakpoints for antimicrobial agents used in susceptibility testing.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="8881117.f1.docx" position="float" orientation="portrait"/></supplementary-material></sec><ref-list><ref id="B1" content-type="article"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores-Mireles</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Walker</surname><given-names>J. N.</given-names></name><name name-style="western"><surname>Caparon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hultgren</surname><given-names>S. J.</given-names></name></person-group><article-title>Urinary Tract Infections: Epidemiology, Mechanisms of Infection and Treatment Options</article-title><source><italic toggle="yes">Nature Reviews Microbiology</italic></source><year>2015</year><volume>13</volume><issue>5</issue><fpage>269</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3432</pub-id><pub-id pub-id-type="other">2-s2.0-84928414071</pub-id><pub-id pub-id-type="pmid">25853778</pub-id><pub-id pub-id-type="pmcid">PMC4457377</pub-id></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manges</surname><given-names>A. R.</given-names></name><name name-style="western"><surname>Geum</surname><given-names>H. M.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Edens</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Fibke</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Pitout</surname><given-names>J. D. D.</given-names></name></person-group><article-title>Global Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic> (ExPEC) Lineages</article-title><source><italic toggle="yes">Clinical Microbiology Reviews</italic></source><year>2019</year><volume>32</volume><issue>3</issue><pub-id pub-id-type="publisher-id">e00135</pub-id><pub-id pub-id-type="doi">10.1128/CMR.00135-18</pub-id><pub-id pub-id-type="other">2-s2.0-85068209567</pub-id><pub-id pub-id-type="pmcid">PMC6589867</pub-id><pub-id pub-id-type="pmid">31189557</pub-id></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nunes</surname><given-names>P. H. S.</given-names></name><name name-style="western"><surname>Valiatti</surname><given-names>T. B.</given-names></name><name name-style="western"><surname>Santos</surname><given-names>A. C. M.</given-names></name><etal/></person-group><article-title>Evaluation of the Pathogenic Potential of <italic toggle="yes">Escherichia coli</italic> Strains Isolated From Eye Infections</article-title><source><italic toggle="yes">Microorganisms</italic></source><year>2022</year><volume>10</volume><issue>6</issue><fpage>p. 1084</fpage><pub-id pub-id-type="doi">10.3390/microorganisms10061084</pub-id><pub-id pub-id-type="pmid">35744602</pub-id><pub-id pub-id-type="pmcid">PMC9229993</pub-id></element-citation></ref><ref id="B4" content-type="incollection"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Barrios-Villa</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pic&#243;n</surname><given-names>L. R.</given-names></name><name name-style="western"><surname>Reynaga</surname><given-names>R. B.</given-names></name><name name-style="western"><surname>Arenas-Hern&#225;ndez</surname><given-names>M. M. P.</given-names></name></person-group><article-title>An Updated Overview on the Resistance and Virulence of UPEC</article-title><source><italic toggle="yes">Trending Topics in Escherichia coli Research: The Latin American Perspective</italic></source><year>2023</year><publisher-name>Springer</publisher-name><fpage>249</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1007/978-3-031-29882-0_11</pub-id></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Denamur</surname><given-names>E.</given-names></name><name name-style="western"><surname>Clermont</surname><given-names>O.</given-names></name><name name-style="western"><surname>Bonacorsi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>D.</given-names></name></person-group><article-title>The Population Genetics of Pathogenic <italic toggle="yes">Escherichia coli</italic></article-title><source><italic toggle="yes">Nature Reviews Microbiology</italic></source><year>2021</year><volume>19</volume><issue>1</issue><fpage>37</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1038/s41579-020-0416-x</pub-id><pub-id pub-id-type="pmid">32826992</pub-id></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yousefipour</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rezatofighi</surname><given-names>S. E.</given-names></name><name name-style="western"><surname>Ardakani</surname><given-names>M. R.</given-names></name></person-group><article-title>Detection and Characterization of Hybrid Uropathogenic <italic toggle="yes">Escherichia coli</italic> Strains Among <italic toggle="yes">E. coli</italic> Isolates Causing Community-Acquired Urinary Tract Infection</article-title><source><italic toggle="yes">Journal of Medical Microbiology</italic></source><year>2023</year><volume>72</volume><issue>2</issue><pub-id pub-id-type="doi">10.1099/jmm.0.001660</pub-id><pub-id pub-id-type="pmid">36753429</pub-id></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naskar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Parekh</surname><given-names>V. P.</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>M. A.</given-names></name><etal/></person-group><article-title>
<italic toggle="yes">&#945;</italic>-Hemolysin Promotes Uropathogenic <italic toggle="yes">E. coli</italic> Persistence in Bladder Epithelial Cells Via Abrogating Bacteria-Harboring Lysosome Acidification</article-title><source><italic toggle="yes">PLoS Pathogens</italic></source><year>2023</year><volume>19</volume><issue>5</issue><pub-id pub-id-type="publisher-id">e1011388</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1011388</pub-id><pub-id pub-id-type="pmid">37167325</pub-id><pub-id pub-id-type="pmcid">PMC10204954</pub-id></element-citation></ref><ref id="B8" content-type="article"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radera</surname><given-names>S.</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>J.</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>A.</given-names></name></person-group><article-title>Association of Virulence Markers With Resistance to Oral Antibiotics in <italic toggle="yes">Escherichia coli</italic> Isolates Causing Uncomplicated Community-Acquired Cystitis</article-title><source><italic toggle="yes">Cureus</italic></source><year>2023</year><volume>15</volume><issue>5</issue><pub-id pub-id-type="publisher-id">e39458</pub-id><pub-id pub-id-type="doi">10.7759/cureus.39458</pub-id><pub-id pub-id-type="pmid">37362452</pub-id><pub-id pub-id-type="pmcid">PMC10290217</pub-id></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abed</surname><given-names>A. D.</given-names></name><name name-style="western"><surname>Mutter</surname><given-names>T. Y.</given-names></name></person-group><article-title>Relationship Between Antimicrobial Resistance and Virulence Factors in Uropathogenic <italic toggle="yes">Escherichia coli</italic> Isolates From Ramadi, Iraq: Phenotype and Genotype Identification</article-title><source><italic toggle="yes">African Health Sciences</italic></source><year>2023</year><volume>23</volume><issue>3</issue><fpage>486</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.4314/ahs.v23i3.56</pub-id><pub-id pub-id-type="pmid">38357165</pub-id><pub-id pub-id-type="pmcid">PMC10862563</pub-id></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belmont-Monroy</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ribas-Aparicio</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Villalobos</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Molecular Typification of <italic toggle="yes">Escherichia coli</italic> From Community-Acquired Urinary Tract Infections in Mexico</article-title><source><italic toggle="yes">International Journal of Antimicrobial Agents</italic></source><year>2022</year><volume>60</volume><issue>4</issue><pub-id pub-id-type="publisher-id">106667</pub-id><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2022.106667</pub-id><pub-id pub-id-type="pmid">36038094</pub-id></element-citation></ref><ref id="B11" content-type="article"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clermont</surname><given-names>O.</given-names></name><name name-style="western"><surname>Christenson</surname><given-names>J. K.</given-names></name><name name-style="western"><surname>Denamur</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>D. M.</given-names></name></person-group><article-title>The Clermont <italic toggle="yes">Escherichia coli</italic> Phylo&#8208;Typing Method Revisited: Improvement of Specificity and Detection of New Phylo-Groups</article-title><source><italic toggle="yes">Environmental Microbiology Reports</italic></source><year>2013</year><volume>5</volume><issue>1</issue><fpage>58</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1111/1758-2229.12019</pub-id><pub-id pub-id-type="other">2-s2.0-84873324306</pub-id><pub-id pub-id-type="pmid">23757131</pub-id></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clermont</surname><given-names>O.</given-names></name><name name-style="western"><surname>Dixit</surname><given-names>O. V. A.</given-names></name><name name-style="western"><surname>Vangchhia</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Characterization and Rapid Identification of Phylogroup G in <italic toggle="yes">Escherichia coli</italic>, a Lineage With High Virulence and Antibiotic Resistance Potential</article-title><source><italic toggle="yes">Environmental Microbiology</italic></source><year>2019</year><volume>21</volume><issue>8</issue><fpage>3107</fpage><lpage>3117</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.14713</pub-id><pub-id pub-id-type="other">2-s2.0-85068344590</pub-id><pub-id pub-id-type="pmid">31188527</pub-id></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baldiris-Avila</surname><given-names>R.</given-names></name><name name-style="western"><surname>Montes-Robledo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Buelvas-Montes</surname><given-names>Y.</given-names></name></person-group><article-title>Phylogenetic Classification, Biofilm-Forming Capacity, Virulence Factors, and Antimicrobial Resistance in Uropathogenic <italic toggle="yes">Escherichia coli</italic> (UPEC)</article-title><source><italic toggle="yes">Current Microbiology</italic></source><year>2020</year><volume>77</volume><issue>11</issue><fpage>3361</fpage><lpage>3370</lpage><pub-id pub-id-type="doi">10.1007/s00284-020-02173-2</pub-id><pub-id pub-id-type="pmid">32910213</pub-id></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballesteros-Monrreal</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Mendez-Pfeiffer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Barrios-Villa</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Uropathogenic <italic toggle="yes">Escherichia coli</italic> in Mexico, an Overview of Virulence and Resistance Determinants: Systematic Review and Meta-Analysis</article-title><source><italic toggle="yes">Archives of Medical Research</italic></source><year>2023</year><volume>54</volume><issue>3</issue><fpage>247</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1016/j.arcmed.2023.01.001</pub-id><pub-id pub-id-type="pmid">36725379</pub-id></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bravata-Alcantara</surname><given-names>J. C.</given-names></name><name name-style="western"><surname>Bello-Lopez</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Cortes-Ortiz</surname><given-names>I. A.</given-names></name><etal/></person-group><article-title>Distribution of Virulence and Antimicrobial Resistance Genes in Phylogenetic Groups of <italic toggle="yes">Escherichia coli</italic> Strains Isolated From Mexican Patients With Urinary Infection</article-title><source><italic toggle="yes">Jundishapur Journal of Microbiology</italic></source><year>2019</year><volume>12</volume><issue>3</issue><pub-id pub-id-type="doi">10.5812/jjm.83711</pub-id><pub-id pub-id-type="other">2-s2.0-85070196719</pub-id></element-citation></ref><ref id="B16" content-type="article"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carmona-Cartaya</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hidalgo-Benito</surname><given-names>M.</given-names></name><name name-style="western"><surname>Borges-Mateus</surname><given-names>L. M.</given-names></name><name name-style="western"><surname>Pereda-Novales</surname><given-names>N.</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Molina</surname><given-names>M. K.</given-names></name><name name-style="western"><surname>Qui&#241;ones-P&#233;rez</surname><given-names>D.</given-names></name></person-group><article-title>Community-Acquired Uropathogenic <italic toggle="yes">Escherichia coli</italic>, Antimicrobial Susceptibility, and Extended-Spectrum Beta-Lactamase Detection</article-title><source><italic toggle="yes">MEDICC Review</italic></source><year>2022</year><volume>24</volume><issue>2</issue><fpage>p. 20</fpage><pub-id pub-id-type="doi">10.37757/mr2022.v24.n2.2</pub-id><pub-id pub-id-type="pmid">35648059</pub-id></element-citation></ref><ref id="B17" content-type="article"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pulingam</surname><given-names>T.</given-names></name><name name-style="western"><surname>Parumasivam</surname><given-names>T.</given-names></name><name name-style="western"><surname>Gazzali</surname><given-names>A. M.</given-names></name><etal/></person-group><article-title>Antimicrobial Resistance: Prevalence, Economic Burden, Mechanisms of Resistance and Strategies to Overcome</article-title><source><italic toggle="yes">European Journal of Pharmaceutical Sciences</italic></source><year>2022</year><volume>170</volume><pub-id pub-id-type="publisher-id">106103</pub-id><pub-id pub-id-type="doi">10.1016/j.ejps.2021.106103</pub-id><pub-id pub-id-type="pmid">34936936</pub-id></element-citation></ref><ref id="B18" content-type="article"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia-Cervantes</surname><given-names>P. C.</given-names></name><name name-style="western"><surname>Casta&#241;eda-Mel&#233;ndrez</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Osuna-Ram&#237;rez</surname><given-names>I.</given-names></name><name name-style="western"><surname>Bernal-Reynaga</surname><given-names>R.</given-names></name></person-group><article-title>Characterization of uropathogenic Escherichia coli strains isolated from the urinary tract of women during pregnancy</article-title><source><italic toggle="yes">Revista Bio Ciencias</italic></source><year>2021</year><volume>8</volume><pub-id pub-id-type="publisher-id">e1123</pub-id><pub-id pub-id-type="doi">10.15741/revbio.08.e1123</pub-id></element-citation></ref><ref id="B19" content-type="article"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uribe-Beltr&#225;n</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Ahumada-Santos</surname><given-names>Y. P.</given-names></name><name name-style="western"><surname>D&#237;az-Camacho</surname><given-names>S. P.</given-names></name><etal/></person-group><article-title>High Prevalence of Multidrug-Resistant <italic toggle="yes">Escherichia coli</italic> Isolates From Children With and Without Diarrhoea and their Susceptibility to the Antibacterial Activity of Extracts/Fractions of Fruits Native to Mexico</article-title><source><italic toggle="yes">Journal of Medical Microbiology</italic></source><year>2017</year><volume>66</volume><issue>7</issue><fpage>972</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1099/jmm.0.000548</pub-id><pub-id pub-id-type="other">2-s2.0-85026630336</pub-id><pub-id pub-id-type="pmid">28742000</pub-id></element-citation></ref><ref id="B20" content-type="article"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahumada-Santos</surname><given-names>Y. P.</given-names></name><name name-style="western"><surname>B&#225;ez-Flores</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>D&#237;az-Camacho</surname><given-names>S. P.</given-names></name><etal/></person-group><article-title>Association of Phylogenetic Distribution and Presence of Integrons With Multidrug Resistance in <italic toggle="yes">Escherichia coli</italic> Clinical Isolates From Children With Diarrhoea</article-title><source><italic toggle="yes">Journal of Infection and Public Health</italic></source><year>2020</year><volume>13</volume><issue>5</issue><fpage>767</fpage><lpage>772</lpage><pub-id pub-id-type="doi">10.1016/j.jiph.2019.11.019</pub-id><pub-id pub-id-type="pmid">31859055</pub-id></element-citation></ref><ref id="B21" content-type="book"><label>21</label><element-citation publication-type="book"><collab>Clinical and Laboratory Standards Institute</collab><source><italic toggle="yes">Performance Standards for Antimicrobial Susceptibility Testing (35th ed., CLSI supplement M100)</italic></source><year>2024</year><publisher-name>Clinical and Laboratory Standards Institute</publisher-name></element-citation></ref><ref id="B22" content-type="article"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruiz</surname><given-names>J.</given-names></name><name name-style="western"><surname>Simon</surname><given-names>K.</given-names></name><name name-style="western"><surname>Horcajada</surname><given-names>J. P.</given-names></name><etal/></person-group><article-title>Differences in Virulence Factors among Clinical Isolates of <italic toggle="yes">Escherichia Coli</italic> Causing Cystitis and Pyelonephritis in Women and Prostatitis in Men</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2002</year><volume>40</volume><issue>12</issue><fpage>4445</fpage><lpage>4449</lpage><pub-id pub-id-type="doi">10.1128/jcm.40.12.4445-4449.2002</pub-id><pub-id pub-id-type="other">2-s2.0-18744365479</pub-id><pub-id pub-id-type="pmid">12454134</pub-id><pub-id pub-id-type="pmcid">PMC154654</pub-id></element-citation></ref><ref id="B23" content-type="article"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>J. R.</given-names></name><name name-style="western"><surname>Stell</surname><given-names>A. L.</given-names></name></person-group><article-title>Extended Virulence Genotypes of <italic toggle="yes">Escherichia Coli</italic> Strains from Patients with Urosepsis in Relation to Phylogeny and Host Compromise</article-title><source><italic toggle="yes">Journal of Infectious Diseases</italic></source><year>2000</year><volume>181</volume><issue>1</issue><fpage>261</fpage><lpage>272</lpage><pub-id pub-id-type="doi">10.1086/315217</pub-id><pub-id pub-id-type="other">2-s2.0-0033963533</pub-id><pub-id pub-id-type="pmid">10608775</pub-id></element-citation></ref><ref id="B24" content-type="article"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xia</surname><given-names>X.</given-names></name><name name-style="western"><surname>Meng</surname><given-names>J.</given-names></name><name name-style="western"><surname>McDermott</surname><given-names>P. F.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name></person-group><article-title>Escherichia coli from retail meats carry genes associated with uropathogenic Escherichia coli, but are weakly invasive in human bladder cell culture</article-title><source><italic toggle="yes">Journal of Applied Microbiology</italic></source><year>2011</year><volume>111</volume><issue>6</issue><fpage>1416</fpage><lpage>1426</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2672.2011.04978.x</pub-id><pub-id pub-id-type="other">2-s2.0-79953741580</pub-id><pub-id pub-id-type="pmid">21332898</pub-id></element-citation></ref><ref id="B25" content-type="article"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>J. R.</given-names></name><name name-style="western"><surname>O&#8217;Bryan</surname><given-names>T. T.</given-names></name></person-group><article-title>Detection of the <italic toggle="yes">Escherichia Coli</italic> Group 2 Polysaccharide Capsule Synthesis Gene <italic toggle="yes">kpsM</italic> by a Rapid and Specific PCR-Based Assay</article-title><source><italic toggle="yes">Journal of Clinical Microbiology</italic></source><year>2004</year><volume>42</volume><issue>4</issue><fpage>1773</fpage><lpage>1776</lpage><pub-id pub-id-type="doi">10.1128/jcm.42.4.1773-1776.2004</pub-id><pub-id pub-id-type="other">2-s2.0-16544387365</pub-id><pub-id pub-id-type="pmid">15071046</pub-id><pub-id pub-id-type="pmcid">PMC387594</pub-id></element-citation></ref><ref id="B26" content-type="article"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Restieri</surname><given-names>C.</given-names></name><name name-style="western"><surname>Garriss</surname><given-names>G.</given-names></name><name name-style="western"><surname>Locas</surname><given-names>M.-C.</given-names></name><name name-style="western"><surname>Dozois</surname><given-names>C. M.</given-names></name></person-group><article-title>Autotransporter-Encoding Sequences Are Phylogenetically Distributed among Escherichia coli Clinical Isolates and Reference Strains</article-title><source><italic toggle="yes">Applied and Environmental Microbiology</italic></source><year>2007</year><volume>73</volume><issue>5</issue><fpage>1553</fpage><lpage>1562</lpage><pub-id pub-id-type="doi">10.1128/AEM.01542-06</pub-id><pub-id pub-id-type="other">2-s2.0-33947205482</pub-id><pub-id pub-id-type="pmid">17220264</pub-id><pub-id pub-id-type="pmcid">PMC1828755</pub-id></element-citation></ref><ref id="B27" content-type="article"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballesteros-Monrreal</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Arenas-Hern&#225;ndez</surname><given-names>M. M. P.</given-names></name><name name-style="western"><surname>Barrios-Villa</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Bacterial Morphotypes as Important Trait for Uropathogenic <italic toggle="yes">Escherichia Coli</italic> Diagnostic; a Virulence-Phenotype-Phylogeny Study</article-title><source><italic toggle="yes">Microorganisms</italic></source><year>2021</year><volume>9</volume><issue>11</issue><fpage>p. 2381</fpage><pub-id pub-id-type="doi">10.3390/microorganisms9112381</pub-id><pub-id pub-id-type="pmid">34835506</pub-id><pub-id pub-id-type="pmcid">PMC8621242</pub-id></element-citation></ref><ref id="B28" content-type="article"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guzman-Hernandez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Contreras-Rodriguez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hernandez-Velez</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Mexican Unpasteurised Fresh Cheeses Are Contaminated With Salmonella spp., Non-O157 Shiga Toxin Producing <italic toggle="yes">Escherichia coli</italic> and Potential Uropathogenic <italic toggle="yes">E. coli</italic> Strains: A Public Health Risk</article-title><source><italic toggle="yes">International Journal of Food Microbiology</italic></source><year>2016</year><volume>237</volume><fpage>10</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2016.08.018</pub-id><pub-id pub-id-type="other">2-s2.0-84982083167</pub-id><pub-id pub-id-type="pmid">27541977</pub-id></element-citation></ref><ref id="B29" content-type="article"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghazvini</surname><given-names>H.</given-names></name><name name-style="western"><surname>Taheri</surname><given-names>E.</given-names></name><name name-style="western"><surname>Edalati</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sedighi</surname><given-names>M.</given-names></name></person-group><article-title>Virulence factors and antimicrobial resistance in uropathogenic Escherichia coli strains isolated from cystitis and pyelonephritis</article-title><source><italic toggle="yes">Turkish Journal of Medical Sciences</italic></source><year>2019</year><volume>49</volume><issue>2</issue><fpage>361</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.3906/sag-1805-100</pub-id><pub-id pub-id-type="other">2-s2.0-85061597648</pub-id><pub-id pub-id-type="pmid">30761847</pub-id><pub-id pub-id-type="pmcid">PMC7350878</pub-id></element-citation></ref><ref id="B30" content-type="article"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lescat</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hoede</surname><given-names>C.</given-names></name><name name-style="western"><surname>Clermont</surname><given-names>O.</given-names></name><etal/></person-group><article-title>
<italic toggle="yes">aes</italic>, the Gene Encoding the Esterase B in <italic toggle="yes">Escherichia coli</italic>, Is a Powerful Phylogenetic Marker of the Species</article-title><source><italic toggle="yes">BMC Microbiology</italic></source><year>2009</year><volume>9</volume><issue>1</issue><fpage>p. 273</fpage><pub-id pub-id-type="doi">10.1186/1471-2180-9-273</pub-id><pub-id pub-id-type="other">2-s2.0-74949113330</pub-id><pub-id pub-id-type="pmid">20040078</pub-id><pub-id pub-id-type="pmcid">PMC2805673</pub-id></element-citation></ref><ref id="B31" content-type="article"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lescat</surname><given-names>M.</given-names></name><name name-style="western"><surname>Clermont</surname><given-names>O.</given-names></name><name name-style="western"><surname>Woerther</surname><given-names>P. L.</given-names></name><etal/></person-group><article-title>Commensal <italic toggle="yes">Escherichia coli</italic> Strains in Guiana Reveal a High Genetic Diversity With Host-Dependant Population Structure</article-title><source><italic toggle="yes">Environmental Microbiology Reports</italic></source><year>2013</year><volume>5</volume><issue>1</issue><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1111/j.1758-2229.2012.00374.x</pub-id><pub-id pub-id-type="other">2-s2.0-84873303939</pub-id><pub-id pub-id-type="pmid">23757130</pub-id></element-citation></ref><ref id="B32" content-type="article"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yescas-Zazueta</surname><given-names>V.</given-names></name><name name-style="western"><surname>Rocha-Gracia</surname><given-names>R. . C.</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Bonilla</surname><given-names>C. R.</given-names></name><etal/></person-group><article-title>Resistance Phenotype and Virulence Potential of <italic toggle="yes">Leclercia adecarboxylata</italic> Strains Isolated From Different Sources</article-title><source><italic toggle="yes">Microbiology</italic></source><year>2024</year><volume>170</volume><issue>4</issue><pub-id pub-id-type="publisher-id">001457</pub-id><pub-id pub-id-type="doi">10.1099/mic.0.001457</pub-id><pub-id pub-id-type="pmcid">PMC11084626</pub-id><pub-id pub-id-type="pmid">38661713</pub-id></element-citation></ref><ref id="B33" content-type="article"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whelan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lucey</surname><given-names>B.</given-names></name><name name-style="western"><surname>Finn</surname><given-names>K.</given-names></name></person-group><article-title>Uropathogenic <italic toggle="yes">Escherichia coli</italic> (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment</article-title><source><italic toggle="yes">Microorganisms</italic></source><year>2023</year><volume>11</volume><issue>9</issue><fpage>p. 2169</fpage><pub-id pub-id-type="doi">10.3390/microorganisms11092169</pub-id><pub-id pub-id-type="pmcid">PMC10537683</pub-id><pub-id pub-id-type="pmid">37764013</pub-id></element-citation></ref><ref id="B34" content-type="article"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Urinary Tract Infections Caused by Uropathogenic <italic toggle="yes">Escherichia coli</italic>: Mechanisms of Infection and Treatment Options</article-title><source><italic toggle="yes">International Journal of Molecular Sciences</italic></source><year>2023</year><volume>24</volume><issue>13</issue><fpage>p. 10537</fpage><pub-id pub-id-type="doi">10.3390/ijms241310537</pub-id><pub-id pub-id-type="pmid">37445714</pub-id><pub-id pub-id-type="pmcid">PMC10341809</pub-id></element-citation></ref><ref id="B35" content-type="article"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballesteros-Monrreal</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Arenas-Hern&#225;ndez</surname><given-names>M. M. P.</given-names></name><name name-style="western"><surname>Enciso-Mart&#237;nez</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Virulence and Resistance Determinants of Uropathogenic <italic toggle="yes">Escherichia coli</italic> Strains Isolated From Pregnant and Non-Pregnant Women From Two States in Mexico</article-title><source><italic toggle="yes">Infection and Drug Resistance</italic></source><year>2020</year><volume>13</volume><fpage>295</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.2147/IDR.S226215</pub-id><pub-id pub-id-type="pmid">32099421</pub-id><pub-id pub-id-type="pmcid">PMC6997036</pub-id></element-citation></ref><ref id="B36" content-type="article"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cortez-de la Puente</surname><given-names>I. M.</given-names></name><name name-style="western"><surname>Lozano-Zarain</surname><given-names>P.</given-names></name><name name-style="western"><surname>Rocha-Gracia</surname><given-names>R. . C.</given-names></name><name name-style="western"><surname>Mart&#237;nez-de la Pe&#241;a</surname><given-names>C.</given-names></name><name name-style="western"><surname>Baca</surname><given-names>B. E.</given-names></name><name name-style="western"><surname>Arenas-Hern&#225;ndez</surname><given-names>M. M. P.</given-names></name></person-group><article-title>
<italic toggle="yes">Escherichia coli</italic> uropat&#243;gena: ejemplo de plasticidad gen&#243;mica</article-title><source><italic toggle="yes">TIP Revista Especializada en Ciencias Qu&#237;mico-Biol&#243;gicas</italic></source><year>2024</year><volume>27</volume><pub-id pub-id-type="doi">10.22201/fesz.23958723e.2024.687</pub-id></element-citation></ref><ref id="B37" content-type="article"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>C.</given-names></name><name name-style="western"><surname>Rantell</surname><given-names>A.</given-names></name></person-group><article-title>Lower Urinary Tract Infections in Women</article-title><source><italic toggle="yes">The British Journal of Nursing</italic></source><year>2017</year><volume>26</volume><issue>9</issue><fpage>S12</fpage><lpage>S19</lpage><pub-id pub-id-type="doi">10.12968/bjon.2017.26.9.S12</pub-id><pub-id pub-id-type="other">2-s2.0-85019173937</pub-id><pub-id pub-id-type="pmid">28493770</pub-id></element-citation></ref><ref id="B38" content-type="article"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#243;pez-Banda</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Carrillo-Casas</surname><given-names>E. M.</given-names></name><name name-style="western"><surname>Leyva-Leyva</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Identification of Virulence Factors Genes in <italic toggle="yes">Escherichia coli</italic> Isolates From Women With Urinary Tract Infection in Mexico</article-title><source><italic toggle="yes">BioMed Research International</italic></source><year>2014</year><volume>2014</volume><pub-id pub-id-type="publisher-id">959206</pub-id><pub-id pub-id-type="doi">10.1155/2014/959206</pub-id><pub-id pub-id-type="other">2-s2.0-84901809156</pub-id><pub-id pub-id-type="pmid">24895634</pub-id><pub-id pub-id-type="pmcid">PMC4026957</pub-id></element-citation></ref><ref id="B39" content-type="article"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramatla</surname><given-names>T.</given-names></name><name name-style="western"><surname>Mafokwane</surname><given-names>T.</given-names></name><name name-style="western"><surname>Lekota</surname><given-names>K.</given-names></name><etal/></person-group><article-title>&#8220;One Health&#8221; Perspective on Prevalence of Co-Existing Extended-Spectrum <italic toggle="yes">&#946;</italic>-Lactamase (ESBL)-Producing <italic toggle="yes">Escherichia coli</italic> and <italic toggle="yes">Klebsiella pneumoniae</italic>: A Comprehensive Systematic Review and Meta-Analysis</article-title><source><italic toggle="yes">Annals of Clinical Microbiology and Antimicrobials</italic></source><year>2023</year><volume>22</volume><issue>1</issue><fpage>p. 88</fpage><pub-id pub-id-type="doi">10.1186/s12941-023-00638-3</pub-id><pub-id pub-id-type="pmcid">PMC10517531</pub-id><pub-id pub-id-type="pmid">37740207</pub-id></element-citation></ref><ref id="B40" content-type="article"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sallem</surname><given-names>N.</given-names></name><name name-style="western"><surname>Ben Mansour</surname><given-names>N.</given-names></name><name name-style="western"><surname>Amri</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Extended-Spectrum Beta-Lactamase- and Carbapenemase-Producing <italic toggle="yes">Escherichia coli</italic> Isolates Causing Hospital- and Community-Acquired Infections in Tunisia (2001&#8211;2019): Expansion of CTX-M-15-C2 and CTX-M-27-C1 ST131 Subclades</article-title><source><italic toggle="yes">Microbiology Spectrum</italic></source><year>2024</year><volume>12</volume><issue>12</issue><pub-id pub-id-type="publisher-id">e0147124</pub-id><pub-id pub-id-type="doi">10.1128/spectrum.01471-24</pub-id><pub-id pub-id-type="pmid">39451135</pub-id><pub-id pub-id-type="pmcid">PMC11619393</pub-id></element-citation></ref><ref id="B41" content-type="article"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Stability and Genetic Insights of the Co-Existence of <italic toggle="yes">bla</italic><sub>CTX-M-65</sub>, <italic toggle="yes">bla</italic><sub>OXA-1</sub>, and <italic toggle="yes">mcr-1.1</italic> Harboring Conjugative IncI2 Plasmid Isolated From a Clinical Extensively-Drug Resistant <italic toggle="yes">Escherichia coli</italic> ST744 in Shanghai</article-title><source><italic toggle="yes">Frontiers in Public Health</italic></source><year>2023</year><volume>11</volume><pub-id pub-id-type="publisher-id">1216704</pub-id><pub-id pub-id-type="doi">10.3389/fpubh.2023.1216704</pub-id><pub-id pub-id-type="pmid">37680274</pub-id><pub-id pub-id-type="pmcid">PMC10481164</pub-id></element-citation></ref><ref id="B42" content-type="article"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colclough</surname><given-names>A.</given-names></name><name name-style="western"><surname>Corander</surname><given-names>J.</given-names></name><name name-style="western"><surname>Sheppard</surname><given-names>S. K.</given-names></name><name name-style="western"><surname>Bayliss</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Vos</surname><given-names>M.</given-names></name></person-group><article-title>Patterns of Cross-Resistance and Collateral Sensitivity Between Clinical Antibiotics and Natural Antimicrobials</article-title><source><italic toggle="yes">Evolutionary Applications</italic></source><year>2019</year><volume>12</volume><issue>5</issue><fpage>878</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1111/eva.12762</pub-id><pub-id pub-id-type="other">2-s2.0-85065405727</pub-id><pub-id pub-id-type="pmid">31080502</pub-id><pub-id pub-id-type="pmcid">PMC6503891</pub-id></element-citation></ref><ref id="B43" content-type="article"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tseng</surname><given-names>C. C.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>W. H.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>A. B.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Teng</surname><given-names>C. H.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J. J.</given-names></name></person-group><article-title>
<italic toggle="yes">Escherichia coli</italic> FimH Adhesins Act Synergistically With PapGII Adhesins for Enhancing Establishment and Maintenance of Kidney Infection</article-title><source><italic toggle="yes">Journal of Microbiology, Immunology, and Infection</italic></source><year>2022</year><volume>55</volume><issue>1</issue><fpage>44</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.jmii.2020.09.001</pub-id><pub-id pub-id-type="pmid">33023843</pub-id></element-citation></ref><ref id="B44" content-type="article"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koley</surname><given-names>S.</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>M.</given-names></name></person-group><article-title>Cytokine Profile in HTB-4 Cells With Respect to fimH, papC and hlyA Expression in Uropathogenic Escherichia coli Invasion</article-title><source><italic toggle="yes">Future Microbiology</italic></source><year>2023</year><volume>18</volume><issue>8</issue><fpage>489</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.2217/fmb-2022-0240</pub-id><pub-id pub-id-type="pmid">37288968</pub-id></element-citation></ref><ref id="B45" content-type="article"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matta-Chuquisapon</surname><given-names>J.</given-names></name><name name-style="western"><surname>Valencia-Bazalar</surname><given-names>E.</given-names></name><name name-style="western"><surname>Marocho-Chahuayo</surname><given-names>L.</given-names></name><name name-style="western"><surname>Gonzales-Escalante</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sevilla-Andrade</surname><given-names>C. R.</given-names></name></person-group><article-title>Presencia de genes <italic toggle="yes">fimH</italic> y <italic toggle="yes">Afa</italic> en aislamientos urinarios de <italic toggle="yes">Escherichia coli</italic> productora de betalactamasas de espectro extendido en Lima, Per&#250;</article-title><source><italic toggle="yes">Revista Peruana de Medicina Experimental Y Salud P&#250;blica</italic></source><year>2020</year><volume>37</volume><issue>2</issue><fpage>282</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.17843/rpmesp.2020.372.4829</pub-id><pub-id pub-id-type="pmid">32876218</pub-id></element-citation></ref><ref id="B46" content-type="article"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tewawong</surname><given-names>N.</given-names></name><name name-style="western"><surname>Kowaboot</surname><given-names>S.</given-names></name><name name-style="western"><surname>Pimainog</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Watanagul</surname><given-names>N.</given-names></name><name name-style="western"><surname>Thongmee</surname><given-names>T.</given-names></name><name name-style="western"><surname>Poovorawan</surname><given-names>Y.</given-names></name></person-group><article-title>Distribution of Phylogenetic Groups, Adhesin Genes, Biofilm Formation, and Antimicrobial Resistance of Uropathogenic <italic toggle="yes">Escherichia coli</italic> Isolated From Hospitalized Patients in Thailand</article-title><source><italic toggle="yes">PeerJ</italic></source><year>2020</year><volume>8</volume><pub-id pub-id-type="publisher-id">e10453</pub-id><pub-id pub-id-type="doi">10.7717/peerj.10453</pub-id><pub-id pub-id-type="pmcid">PMC7718785</pub-id><pub-id pub-id-type="pmid">33344087</pub-id></element-citation></ref><ref id="B47" content-type="article"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foster-Nyarko</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pallen</surname><given-names>M. J.</given-names></name></person-group><article-title>The Microbial Ecology of <italic toggle="yes">Escherichia coli</italic> in the Vertebrate Gut</article-title><source><italic toggle="yes">FEMS Microbiology Reviews</italic></source><year>2022</year><volume>46</volume><issue>3</issue><pub-id pub-id-type="publisher-id">fuac008</pub-id><pub-id pub-id-type="doi">10.1093/femsre/fuac008</pub-id><pub-id pub-id-type="pmid">35134909</pub-id><pub-id pub-id-type="pmcid">PMC9075585</pub-id></element-citation></ref><ref id="B48" content-type="article"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sarowska</surname><given-names>J.</given-names></name><name name-style="western"><surname>Futoma-Koloch</surname><given-names>B.</given-names></name><name name-style="western"><surname>Jama-Kmiecik</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Virulence Factors, Prevalence and Potential Transmission of Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic> Isolated From Different Sources: Recent Reports</article-title><source><italic toggle="yes">Gut Pathogens</italic></source><year>2019</year><volume>11</volume><issue>1</issue><fpage>p. 10</fpage><pub-id pub-id-type="doi">10.1186/s13099-019-0290-0</pub-id><pub-id pub-id-type="other">2-s2.0-85062477213</pub-id><pub-id pub-id-type="pmcid">PMC6383261</pub-id><pub-id pub-id-type="pmid">30828388</pub-id></element-citation></ref><ref id="B49" content-type="article"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sora</surname><given-names>V. M.</given-names></name><name name-style="western"><surname>Meroni</surname><given-names>G.</given-names></name><name name-style="western"><surname>Martino</surname><given-names>P. A.</given-names></name><name name-style="western"><surname>Soggiu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Bonizzi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zecconi</surname><given-names>A.</given-names></name></person-group><article-title>Extraintestinal Pathogenic <italic toggle="yes">Escherichia coli</italic>: Virulence Factors and Antibiotic Resistance</article-title><source><italic toggle="yes">Pathogens</italic></source><year>2021</year><volume>10</volume><issue>11</issue><fpage>p. 1355</fpage><pub-id pub-id-type="doi">10.3390/pathogens10111355</pub-id><pub-id pub-id-type="pmcid">PMC8618662</pub-id><pub-id pub-id-type="pmid">34832511</pub-id></element-citation></ref><ref id="B50" content-type="article"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Praetorius</surname><given-names>H.</given-names></name></person-group><article-title>The Bacteria and the Host: A Story of Purinergic Signaling in Urinary Tract Infections</article-title><source><italic toggle="yes">American Journal of Physiology-Cell Physiology</italic></source><year>2021</year><volume>321</volume><issue>1</issue><fpage>C134</fpage><lpage>C146</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00054.2021</pub-id><pub-id pub-id-type="pmid">33979212</pub-id></element-citation></ref><ref id="B51" content-type="article"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammed</surname><given-names>E. J.</given-names></name><name name-style="western"><surname>Hasan</surname><given-names>K. C.</given-names></name><name name-style="western"><surname>Allami</surname><given-names>M.</given-names></name></person-group><article-title>Phylogenetic Groups, Serogroups and Virulence Factors of Uropathogenic <italic toggle="yes">Escherichia coli</italic> Isolated From Patients With Urinary Tract Infection in Baghdad, Iraq</article-title><source><italic toggle="yes">Iranian Journal of Microbiology</italic></source><year>2022</year><volume>14</volume><issue>4</issue><fpage>445</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.18502/ijm.v14i4.10230</pub-id><pub-id pub-id-type="pmid">36721510</pub-id><pub-id pub-id-type="pmcid">PMC9867636</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="fig1" orientation="portrait"><label>Figure 1</label><caption><p>Relationships between different antibiotics by Circos plot. Antibiotics are displayed around the outer circle (ampicillin (AMP), ampicillin/sulbactam (SAM), piperacillin/tazobactam (PIP), cefazolin (CFZ1), cefazolin (urine) (CFZ2), ceftriaxone (CRO), cefepime (FEP), aztreonam (ATM), ertapenem (ETP), meropenem (MEM), amikacin (AMK), gentamicin (GEN), tobramycin (TOB), ciprofloxacin (CIP), tigecycline (TGC), nitrofurantoin (NIT), trimethoprim/sulfamethoxazole (STX), cephalothin (CEP), cefuroxime (CXM), cefuroxime axetil (CTX), cefotaxime (CTC), ceftazidime (CAZ), norfloxacin (NOR), fosfomycin (FOS), and amoxicillin (AMX)). The small bar charts above each label represent the percentage of isolates resistant to each antibiotic. Lines connecting antibiotics indicate shared resistance patterns across isolates and were inferred based on visual inspection of resistance data, without formal statistical testing. Line thickness corresponds to the number of shared resistant isolates between antibiotic pairs. This visualization provides a qualitative overview of potential cross-resistance relationships among antibiotic classes.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="IJMICRO2025-8881117.001.jpg"/></fig><table-wrap position="float" id="tab1" orientation="portrait"><label>Table 1</label><caption><p>Primer sequences and amplicon sizes of the virulence genes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Protocol</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Gene</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Sequence (5</bold>&#8291;&#8242;<bold>-3</bold>&#8291;&#8242;<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Size (pb)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Concentration (pMol)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Reference</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Hemolysin</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">hlyA</italic>
</td><td align="center" rowspan="1" colspan="1">F: AACAAGGATAAGCACTGTTCT</td><td align="center" rowspan="2" colspan="1">1177</td><td align="center" rowspan="2" colspan="1">1.5</td><td align="center" rowspan="2" colspan="1">[<xref rid="B22" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: ACCATATAAGCGGTCATTCCC</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="10" colspan="1">ExPEC</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">papC</italic>
</td><td align="center" rowspan="1" colspan="1">F: ACGGCTGTACTGCAGGGTGTGGCG</td><td align="center" rowspan="2" colspan="1">328</td><td align="center" rowspan="2" colspan="1">1.5</td><td align="center" rowspan="2" colspan="1">[<xref rid="B22" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: ATATCCTTTCTGCAGGGATGCAATA</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">cnf1</italic>
</td><td align="center" rowspan="1" colspan="1">F: AAGATGGAGTTTCCTATGCAGGAG</td><td align="center" rowspan="2" colspan="1">498</td><td align="center" rowspan="2" colspan="1">1.5</td><td align="center" rowspan="2" colspan="1">[<xref rid="B22" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: CATTCAGAGTCCTGCCCTCATTATT</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">fimA</italic>
</td><td align="center" rowspan="1" colspan="1">F: GTTGTTCTGTCGGCTCTGTC</td><td align="center" rowspan="2" colspan="1">447</td><td align="center" rowspan="2" colspan="1">10</td><td align="center" rowspan="2" colspan="1">[<xref rid="B22" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: ATGGTGTTGGTTCCGTTATTC</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">fyuA</italic>
</td><td align="center" rowspan="1" colspan="1">F: TGATTAACCCCGCGACGGGAA</td><td align="center" rowspan="2" colspan="1">785</td><td align="center" rowspan="2" colspan="1">1.5</td><td align="center" rowspan="2" colspan="1">[<xref rid="B23" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: CGCAGTAGGCACGATGTTGTA</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">vat</italic>
</td><td align="center" rowspan="1" colspan="1">F: AGAGACGAGACTGTATTTGC</td><td align="center" rowspan="2" colspan="1">289</td><td align="center" rowspan="2" colspan="1">5</td><td align="center" rowspan="2" colspan="1">[<xref rid="B24" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: GTCAGGTCAGTAACGAGCAC</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="8" colspan="1">UPEC</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">iroN</italic>
</td><td align="center" rowspan="1" colspan="1">F: AAGTCAAAGCAGGGGTTGCCCG</td><td align="center" rowspan="2" colspan="1">667</td><td align="center" rowspan="2" colspan="1">1.7</td><td align="center" rowspan="2" colspan="1">[<xref rid="B24" ref-type="bibr">24</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: GACGCCGACATTAAGACGCAG</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">kpsmTII</italic>
</td><td align="center" rowspan="1" colspan="1">F: GCGCATTTGCTGATACTGTTG</td><td align="center" rowspan="2" colspan="1">578</td><td align="center" rowspan="2" colspan="1">30</td><td align="center" rowspan="2" colspan="1">[<xref rid="B25" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: AGGTAGTTCAGACTCACACCT</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">agn43</italic>
</td><td align="center" rowspan="1" colspan="1">F: CTGGAAACCGGTCTGCCCTT</td><td align="center" rowspan="2" colspan="1">433</td><td align="center" rowspan="2" colspan="1">2</td><td align="center" rowspan="2" colspan="1">[<xref rid="B26" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: CCTGAACGCCCAGGGTGATA</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">iutA</italic>
</td><td align="center" rowspan="1" colspan="1">F: GGCTGGACATCATGGGAACTGG</td><td align="center" rowspan="2" colspan="1">302</td><td align="center" rowspan="2" colspan="1">2.5</td><td align="center" rowspan="2" colspan="1">[<xref rid="B23" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: CGTCGGGAACGGGTAGAATCG</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="2" colspan="1">
<italic toggle="yes">fimH</italic>
</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">fimH</italic>
</td><td align="center" rowspan="1" colspan="1">F: TTATGGCGGCGTGTTATC</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">R: TCCCTACTGCTCCTAACG</td><td align="center" rowspan="1" colspan="1">545</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">[<xref rid="B27" ref-type="bibr">27</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>
<italic toggle="yes">Note:</italic> Adapted from Guzm&#225;n-Hern&#225;ndez et al. [<xref rid="B28" ref-type="bibr">28</xref>].</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tab2" orientation="portrait"><label>Table 2</label><caption><p>Primer sequences and amplicon sizes used in the phylo-typing method.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Protocol</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Gene</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Sequence (5</bold>&#8291;&#8242;<bold>-3</bold>&#8291;&#8242;<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Size (pb)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Concentration (pMol)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Reference</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="8" colspan="1">Quadruplex</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">chuA</italic>
</td><td align="center" rowspan="1" colspan="1">chuA.1b ATGGTACCGGACGAACCAAC</td><td align="center" rowspan="2" colspan="1">288</td><td align="center" rowspan="2" colspan="1">0.2</td><td align="center" rowspan="8" colspan="1">[<xref rid="B11" ref-type="bibr">11</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">chuA.2 GCCGCCAGTACCAAAGACA</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">yjaA</italic>
</td><td align="center" rowspan="1" colspan="1">yjaA.1b CAAACGTGAAGTGTCAGGAG</td><td align="center" rowspan="2" colspan="1">211</td><td align="center" rowspan="2" colspan="1">0.2</td></tr><tr><td align="center" rowspan="1" colspan="1">yjaA.2b AATGCGTTCCTCAACCTGTG</td></tr><tr><td align="center" rowspan="2" colspan="1">TspE4.C2</td><td align="center" rowspan="1" colspan="1">TspE4C2.1b CACTATTCGTAAGGTCATCC</td><td align="center" rowspan="2" colspan="1">152</td><td align="center" rowspan="2" colspan="1">0.2</td></tr><tr><td align="center" rowspan="1" colspan="1">TspE4C2.2b AGTTTATCGCTGCGGGTCGC</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">arpA</italic>
</td><td align="center" rowspan="1" colspan="1">AceK.f AACGCTATTCGCCAGCTTGC</td><td align="center" rowspan="2" colspan="1">785</td><td align="center" rowspan="2" colspan="1">0.2</td></tr><tr><td align="center" rowspan="1" colspan="1">ArpA1.r TCTCCCCATACCGTACGCTA</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="2" colspan="1">Group E</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">arpA</italic>
</td><td align="center" rowspan="1" colspan="1">ArpAgpE.f GATTCCATCTTGTCAAAATATGCC</td><td align="center" rowspan="2" colspan="1">301</td><td align="center" rowspan="2" colspan="1">0.2</td><td align="center" rowspan="4" colspan="1">[<xref rid="B30" ref-type="bibr">30</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">ArpAgpE.r GAAAAGAAAAAGAATTCCCAAGAG</td></tr><tr><td align="left" rowspan="2" colspan="1">Group C</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">trpA</italic>
</td><td align="center" rowspan="1" colspan="1">trpAgpC.1 AGTTTTATGCCCAGTGCGAG</td><td align="center" rowspan="2" colspan="1">219</td><td align="center" rowspan="2" colspan="1">0.2</td></tr><tr><td align="center" rowspan="1" colspan="1">trpAgpC.2 TCTGCGCCGGTCACGCCC</td></tr><tr><td align="center" colspan="6" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="2" colspan="1">Group G</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">ybgD</italic>
</td><td align="center" rowspan="1" colspan="1">ybgD.1 TATGCGGCTGATGAAGGATC-</td><td align="center" rowspan="2" colspan="1">177</td><td align="center" rowspan="2" colspan="1">0.2</td><td align="center" rowspan="4" colspan="1">[<xref rid="B12" ref-type="bibr">12</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">ybgD.2 GTTGACTAAGCGCAGGTCGA</td></tr><tr><td align="left" rowspan="2" colspan="1">Group F</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">cfaB</italic>
</td><td align="center" rowspan="1" colspan="1">cfaB.1 CTAACGTTGATGCTGCTCTG</td><td align="center" rowspan="2" colspan="1">384</td><td align="center" rowspan="2" colspan="1">0.2</td></tr><tr><td align="center" rowspan="1" colspan="1">cfaB.2 TGCTAACTACGCCACGGTAG</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tab3" orientation="portrait"><label>Table 3</label><caption><p>Primer sequences and amplicon sizes of <italic toggle="yes">&#946;</italic>-lactamase genes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Protocol</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Gene</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Sequence (5</bold>&#8291;&#8242;<bold>-3</bold>&#8291;&#8242;<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Size (pb)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Concentration (pMol)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Reference</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">
<italic toggle="yes">blaOXA48</italic>
</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">blaOXA48</italic>
</td><td align="center" rowspan="1" colspan="1">F: GATTTTTCGATGGGACGGCG</td><td align="center" rowspan="2" colspan="1">500 pb</td><td align="center" rowspan="2" colspan="1">0.4</td><td align="center" rowspan="6" colspan="1">[<xref rid="B32" ref-type="bibr">32</xref>]</td></tr><tr><td align="center" rowspan="1" colspan="1">R: ATAGAGCGAAGGATTGCCCG</td></tr><tr><td align="left" rowspan="2" colspan="1">
<italic toggle="yes">blaCTX-M1-8</italic>
</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">blaCTX-M1-8</italic>
</td><td align="center" rowspan="1" colspan="1">F: TGTGCAGYACCAGTAARGYKATG</td><td align="center" rowspan="2" colspan="1">583 pb</td><td align="center" rowspan="2" colspan="1">0.4</td></tr><tr><td align="center" rowspan="1" colspan="1">R: TARRTSACCAGAAYVAGCGGC</td></tr><tr><td align="left" rowspan="2" colspan="1">
<italic toggle="yes">blaCTX-M9</italic>
</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">blaCTX-M9</italic>
</td><td align="center" rowspan="1" colspan="1">F: ATGGTGACAAAGAGAGTGCAA</td><td align="center" rowspan="2" colspan="1">747 pb</td><td align="center" rowspan="2" colspan="1">0.4</td></tr><tr><td align="center" rowspan="1" colspan="1">R: AATATCATTGGTGGTGCCGTAG</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tab4" content-type="sidewaystable" orientation="portrait"><label>Table 4</label><caption><p>Patient characteristics and origin of the isolates.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2" colspan="1">
<bold>Patients</bold>
</th><th align="center" colspan="10" rowspan="1">
<bold>Isolates (<italic toggle="yes">N</italic>&#8201;=&#8201;200)</bold>
</th></tr><tr><th align="center" rowspan="1" colspan="1">
<bold>Urinary culture</bold>
<break/>(<bold>n</bold> = 163<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Wound</bold>
<break/>(<bold>n</bold> = 18<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Sputum</bold>
<break/>(<bold>n</bold> = 6<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Blood culture</bold>
<break/>(<bold>n</bold> = 4<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Catheter</bold>
<break/>(<bold>n</bold> = 3<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Peritoneal fluid</bold>
<break/>(<bold>n</bold> = 2<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Bronchial aspirate</bold>
<break/>(<bold>n</bold> = 1<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Ascitic fluid</bold>
<break/>(<bold>n</bold> = 1<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Otic</bold>
<break/>(<bold>n</bold> = 1<bold>)</bold></th><th align="center" rowspan="1" colspan="1">
<bold>Hemodialysis</bold>
<break/>(<bold>n</bold> = 1<bold>)</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">74</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">89</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Age range</td><td align="center" rowspan="1" colspan="1">9&#8211;93&#8201;yo</td><td align="center" rowspan="1" colspan="1">32&#8211;84&#8201;yo</td><td align="center" rowspan="1" colspan="1">43&#8211;81&#8201;yo</td><td align="center" rowspan="1" colspan="1">41&#8211;69&#8201;yo</td><td align="center" rowspan="1" colspan="1">38&#8211;62&#8201;yo</td><td align="center" rowspan="1" colspan="1">62&#8211;69&#8201;yo</td><td align="center" rowspan="1" colspan="1">78&#8201;yo</td><td align="center" rowspan="1" colspan="1">71&#8201;yo</td><td align="center" rowspan="1" colspan="1">69&#8201;yo</td><td align="center" rowspan="1" colspan="1">48&#8201;yo</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Wards</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Ambulatory surgery</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;General surgery</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Outpatient consultation</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hemodialysis</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Internal medicine</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Neurosurgery</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Pediatrics</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Operating room</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Traumatology</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Intensive care unit</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Pediatric intensive care unit</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Adult emergencies</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Pediatric emergencies</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Unspecified service</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tab5" orientation="portrait"><label>Table 5</label><caption><p>Prevalence of virulence factors in phylogenetic groups of extraintestinal <italic toggle="yes">Escherichia coli</italic> isolates.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2" rowspan="1">
<bold>Phylogroup</bold>
</th><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">
<bold>A</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>B1</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>B2</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>C</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>D</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>E</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>F</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>G</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>UNK</bold>
</th></tr></thead><tbody><tr><td align="left" colspan="2" rowspan="2">Virulence factors</td><td align="center" rowspan="1" colspan="1">
<bold>n</bold>
</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">92</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="center" rowspan="1" colspan="1">
<bold>(%)</bold>
</td><td align="center" rowspan="1" colspan="1">(13.5)</td><td align="center" rowspan="1" colspan="1">(8)</td><td align="center" rowspan="1" colspan="1">(46)</td><td align="center" rowspan="1" colspan="1">(4)</td><td align="center" rowspan="1" colspan="1">(8.5)</td><td align="center" rowspan="1" colspan="1">(10.5)</td><td align="center" rowspan="1" colspan="1">(4.5)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(5)</td></tr><tr><td align="center" colspan="12" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="6" colspan="1">Adhesins</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">papC</italic>
</td><td align="center" rowspan="1" colspan="1">124</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">63</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td align="center" rowspan="1" colspan="1">(62)</td><td align="center" rowspan="1" colspan="1">(12.9)</td><td align="center" rowspan="1" colspan="1">(11.2)</td><td align="center" rowspan="1" colspan="1">(50.8)</td><td align="center" rowspan="1" colspan="1">(4.8)</td><td align="center" rowspan="1" colspan="1">(8.0)</td><td align="center" rowspan="1" colspan="1">(4.8)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(5.6)</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">fimA</italic>
</td><td align="center" rowspan="1" colspan="1">68</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td align="center" rowspan="1" colspan="1">(34)</td><td align="center" rowspan="1" colspan="1">(8.8)</td><td align="center" rowspan="1" colspan="1">(2.9)</td><td align="center" rowspan="1" colspan="1">(51.4)</td><td align="center" rowspan="1" colspan="1">(5.8)</td><td align="center" rowspan="1" colspan="1">(7.3)</td><td align="center" rowspan="1" colspan="1">(13.2)</td><td align="center" rowspan="1" colspan="1">(2.9)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(7.3)</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">fimH</italic>
</td><td align="center" rowspan="1" colspan="1">191</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">86</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="center" rowspan="1" colspan="1">(95.5)</td><td align="center" rowspan="1" colspan="1">(13.6)</td><td align="center" rowspan="1" colspan="1">(8.3)</td><td align="center" rowspan="1" colspan="1">(45.0)</td><td align="center" rowspan="1" colspan="1">(4.7)</td><td align="center" rowspan="1" colspan="1">(8.3)</td><td align="center" rowspan="1" colspan="1">(10.4)</td><td align="center" rowspan="1" colspan="1">(4.1)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(5.2)</td></tr><tr><td align="center" colspan="12" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="4" colspan="1">Toxins</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">vat</italic>
</td><td align="center" rowspan="1" colspan="1">49</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td align="center" rowspan="1" colspan="1">(24.5)</td><td align="center" rowspan="1" colspan="1">(3.7)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(65.3)</td><td align="center" rowspan="1" colspan="1">(2.0)</td><td align="center" rowspan="1" colspan="1">(12.2)</td><td align="center" rowspan="1" colspan="1">(2.0)</td><td align="center" rowspan="1" colspan="1">(2.0)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(12.2)</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">hlyA</italic>
</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="center" rowspan="1" colspan="1">(16.5)</td><td align="center" rowspan="1" colspan="1">(6.0)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(75.7)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(12.1)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(6.0)</td></tr><tr><td align="center" colspan="12" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="6" colspan="1">Nutrition</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">iroN</italic>
</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="center" rowspan="1" colspan="1">(10)</td><td align="center" rowspan="1" colspan="1">(10)</td><td align="center" rowspan="1" colspan="1">(10)</td><td align="center" rowspan="1" colspan="1">(35)</td><td align="center" rowspan="1" colspan="1">(10)</td><td align="center" rowspan="1" colspan="1">(20)</td><td align="center" rowspan="1" colspan="1">(5)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(10)</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">fyuA</italic>
</td><td align="center" rowspan="1" colspan="1">126</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">65</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">10</td></tr><tr><td align="center" rowspan="1" colspan="1">(63)</td><td align="center" rowspan="1" colspan="1">(11.9)</td><td align="center" rowspan="1" colspan="1">(3.9)</td><td align="center" rowspan="1" colspan="1">(51.5)</td><td align="center" rowspan="1" colspan="1">(3.9)</td><td align="center" rowspan="1" colspan="1">(8.7)</td><td align="center" rowspan="1" colspan="1">(7.9)</td><td align="center" rowspan="1" colspan="1">(3.9)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(7.9)</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">iutA</italic>
</td><td align="center" rowspan="1" colspan="1">148</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">67</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">8</td></tr><tr><td align="center" rowspan="1" colspan="1">(74)</td><td align="center" rowspan="1" colspan="1">(15.5)</td><td align="center" rowspan="1" colspan="1">(7.4)</td><td align="center" rowspan="1" colspan="1">(45.2)</td><td align="center" rowspan="1" colspan="1">(5.4)</td><td align="center" rowspan="1" colspan="1">(8.1)</td><td align="center" rowspan="1" colspan="1">(10.1)</td><td align="center" rowspan="1" colspan="1">(2.7)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(5.4)</td></tr><tr><td align="center" colspan="12" rowspan="1">
<hr/>
</td></tr><tr><td align="left" rowspan="4" colspan="1">Membrane</td><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">agn43</italic>
</td><td align="center" rowspan="1" colspan="1">164</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">82</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">9</td></tr><tr><td align="center" rowspan="1" colspan="1">(82)</td><td align="center" rowspan="1" colspan="1">(10.3)</td><td align="center" rowspan="1" colspan="1">(7.9)</td><td align="center" rowspan="1" colspan="1">(50)</td><td align="center" rowspan="1" colspan="1">(3.6)</td><td align="center" rowspan="1" colspan="1">(8.5)</td><td align="center" rowspan="1" colspan="1">(10.3)</td><td align="center" rowspan="1" colspan="1">(3.6)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(5.4)</td></tr><tr><td align="center" rowspan="2" colspan="1">
<italic toggle="yes">kpsmTII</italic>
</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">45</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="center" rowspan="1" colspan="1">(34.5)</td><td align="center" rowspan="1" colspan="1">(4.3)</td><td align="center" rowspan="1" colspan="1">(4.3)</td><td align="center" rowspan="1" colspan="1">(65.2)</td><td align="center" rowspan="1" colspan="1">(2.8)</td><td align="center" rowspan="1" colspan="1">(10.1)</td><td align="center" rowspan="1" colspan="1">(5.7)</td><td align="center" rowspan="1" colspan="1">(2.8)</td><td align="center" rowspan="1" colspan="1">&#8212;</td><td align="center" rowspan="1" colspan="1">(4.3)</td></tr></tbody></table><table-wrap-foot><fn><p>
<italic toggle="yes">Note: N</italic> = 200.</p></fn><fn><p>Abbreviation: UNK, unknown.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tab6" orientation="portrait"><label>Table 6</label><caption><p>Most represented profiles of isolates with multiple virulence genes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Virulence gene profiles</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>No. of positive isolates</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">hlyA</italic>&#8201;+&#8201;<italic toggle="yes">papC</italic>&#8201;+&#8201;<italic toggle="yes">fyuA</italic>&#8201;+&#8201;<italic toggle="yes">fimA</italic>&#8201;+&#8201;<italic toggle="yes">vat</italic>&#8201;+&#8201;<italic toggle="yes">iroN</italic>&#8201;+&#8201;<italic toggle="yes">kpsmTII</italic>&#8201;+&#8201;<italic toggle="yes">agn43</italic>&#8201;+&#8201;<italic toggle="yes">iutA&#8201;+&#8201;fimH</italic></td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">hlyA</italic>&#8201;+&#8201;<italic toggle="yes">papC</italic>&#8201;+&#8201;<italic toggle="yes">fyuA</italic>&#8201;+&#8201;<italic toggle="yes">vat</italic>&#8201;+&#8201;<italic toggle="yes">iroN</italic>&#8201;+&#8201;<italic toggle="yes">kpsmTII</italic>&#8201;+&#8201;<italic toggle="yes">agn43</italic>&#8201;+&#8201;<italic toggle="yes">iutA&#8201;+&#8201;fimH</italic></td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">hlyA</italic>&#8201;+&#8201;<italic toggle="yes">papC</italic>&#8201;+&#8201;<italic toggle="yes">fyuA</italic>&#8201;+&#8201;<italic toggle="yes">fimA</italic>&#8201;+&#8201;<italic toggle="yes">vat</italic>&#8201;+&#8201;<italic toggle="yes">iroN</italic>&#8201;+&#8201;<italic toggle="yes">agn43</italic>&#8201;+&#8201;<italic toggle="yes">iutA&#8201;+&#8201;fimH</italic></td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">agn43</italic>&#8201;+&#8201;<italic toggle="yes">iutA&#8201;+&#8201;fimH</italic></td><td align="center" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">hlyA</italic>&#8201;+&#8201;<italic toggle="yes">papC</italic>&#8201;+&#8201;<italic toggle="yes">fyuA</italic>&#8201;+&#8201;<italic toggle="yes">fimA</italic>&#8201;+&#8201;<italic toggle="yes">vat</italic>&#8201;+&#8201;<italic toggle="yes">kpsmTII</italic>&#8201;+&#8201;<italic toggle="yes">agn43</italic>&#8201;+&#8201;<italic toggle="yes">iutA&#8201;+&#8201;fimH</italic></td><td align="center" rowspan="1" colspan="1">9</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">papC</italic>&#8201;+&#8201;<italic toggle="yes">agn43</italic>&#8201;+&#8201;<italic toggle="yes">iutA&#8201;+&#8201;fimH</italic></td><td align="center" rowspan="1" colspan="1">9</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">papC</italic>&#8201;+&#8201;<italic toggle="yes">fyuA</italic>&#8201;+&#8201;<italic toggle="yes">kpsmTII</italic>&#8201;+&#8201;<italic toggle="yes">agn43</italic>&#8201;+&#8201;<italic toggle="yes">iutA&#8201;+&#8201;fimH</italic></td><td align="center" rowspan="1" colspan="1">17</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>